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A new vision for 
Route 34
4







Tens of thousands of simultaneous experiments on 
gene function? It’s all in a day’s work at the Center for 
High Throughput Cell Biology, one of the first groups  
to move into Yale’s West Campus.
12
High-speed science
o n the cov er  The Center for 
High Throughput Cell Biology 
relies on complex robots, laser 
microscopes, and vast computing 
power to determine the func-
tions of genes. Automated plate 
handlers in the high throughput 
cell biology core can batch-process 
tens of thousands of cell-based 
assays simultaneously, using 
small interfering rnas to silence 
individual genes. 
this  page  Vapor from a liquid 
nitrogen freezer hugs the floor in 
the center’s laboratory space on 
Yale’s 136-acre West Campus. The 
former Bayer Healthcare facility 
was purchased by the university 
in 2007; construction of the high 
throughput facility in a portion of 
the space began in July 2008.
o n the back cov er  Jason  
Ignatius is one of 16 people working 
in the new center at West Campus.
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More premed courses 
should be required
I applaud and agree with the 
concepts expressed in “Reform of 
Premed Education Under Way” 
[Yale Medicine, Winter 2009].
My own case in point: I went 
to Stanford as an undergraduate, 
majoring in biology and chem-
istry. I took organic chemistry 
as a freshman, and took two 
statistics courses and a general 
psychology course, all of which 
should be required. I wanted to 
take biochemistry, but was not 
allowed to, since I was a premedi- 
cal student and would have the 
same course in medical school.  
I took virtually every other chem-
istry course offered, including 
the second-year/graduate bio-
chemistry courses—17 chemistry 
courses in all.
I would wish to require the 
following courses or the equiva-
lent knowledge for premedical 
students, in addition to the 
liberal arts components: general 
statistics, biochemistry, and 
psychology. My own experience 
of 40 years in practice has made 
me aware of the need to under-
stand business principles and 
such diverse topics as cultural 
and religious viewpoints toward 
health. I presume that computer 
literacy is a given (I typed my 
m.d. thesis in 1960 on a portable 
typewriter over and over until  
I got it right). 
As the article by Jennifer 
Kaylin suggests, it would be 
wonderful if there were some 
preparatory coursework for 
beginning medical students 
covering the wide scope of world-
views and personal interactions 
needed by caring and capable 
physicians. As an oncologist, I 
have developed productive and 
useful ways of dealing with 
terminal illness that are seldom 
shared with health care profes-
sionals. As Averill Liebow, m.d., 
told us in 1958, “You are students 
of medicine, not schoolboys.”
Malin Dollinger, m.d. ’60
Palos Verdes, Calif.
Propaganda and the law of 
unintended consequences
I am sorry I cannot be in New 
Haven to see the exhibit of anti-
VD posters used by the armed 
forces in World War II. It brings 
back some poignant memories 
[“Cautionary Tales for WWII GIs,” 
Yale Medicine, Spring 2009].
I served in 1946 as radiologist 
to the 155th Station Hospital in 
Yokohama, Japan, also serving 
as pharmacy officer along with 
responsibility for two VD wards 
and VD education for our own 
hospital detachment. In the lat-
ter capacity I was required to 
give a series of lectures and to 
use posters, and more impor-
tantly, a series of excellent mov-
ies with story lines regarding the 
dangers of unsafe sex.
The Army was segregated in 
those days, and we had differ-
ent movies for white and black 
soldiers. The femme fatale in 
the black movie was one of the 
most beautiful and provocative 
females I had ever seen. I was sur-
prised when I received requests 
from our white GIs to show the 
black movie rather than the 
other. During this period I was 
informed by 8th Army HQ that 
the VD rate in the hospital was 
starting to rise.
It was suggested by an old 
sergeant that I try showing the 
movies at the beginning of the 
day rather than just before the 
end. I was too inexperienced 
to realize that when the boys 
watched the temptress at work 
their hormone titers rose to 
astronomical heights and they 
immediately sought out the 
nearest brothel. When the film 
was shown early, its effects 
had a whole day to wear off. 
Although the new timing was 
not a popular move, the VD 
rate did drop to more manage-
able levels.
So while the propaganda 
might have had some positive 
results, it fell victim to the Law 
of Unintended Consequences. 
This was one of the best les-
sons I took home from my mili-
tary career. 
Raymond A. Gagliardi, m.d. ’45
Boca Raton, Fla.
correction
A photograph that appeared 
in “200 Years of Medicine at 
Yale,” [Yale Medicine, Spring 
2009, page 20] was incorrectly 
credited. The photograph is 
part of the A.C. Gilbert Papers, 
Manuscripts and Archives, 
Sterling Memorial Library.
how to reach us
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or fewer) and 
news items to Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style, and content.
visit us on the web
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3starting point
Our thanks go to all of you who participated in our reader-
ship survey, not only for taking the time to reply, but also for 
the enthusiastic support you have shown for Yale Medicine. 
Most of you like what we’re doing, but you also gave us ideas 
about how to do better. More than two-thirds of you ranked 
Yale Medicine “above average” or “among the best” alumni 
magazines you read, and almost 60 percent of you feel more 
engaged with the School of Medicine after reading Yale 
Medicine. You liked our mix of articles, but about half of you asked for more in-depth articles 
about medicine and science, and many of you asked for more news of alumni and faculty.
We will be thinking about your ideas, suggestions, and responses as we begin our redesign 
of Yale Medicine. The survey was the necessary first step prior to redesigning—we wanted to 
know what you, our readers, think about the magazine. For more on the survey, visit yalemedi-
cine.yale.edu/readersurvey.
You will have noticed by now that the issue you hold in your hands is thinner than usual. 
The current economy has forced us to cut back, so this issue has just 32 pages, not the usual 48. 
To continue providing you with news of the School of Medicine, we’ve moved some of our con-
tent to the Web. Throughout the magazine you’ll see references and links to online-only content.
We hope that you continue to enjoy Yale Medicine and that it continues to keep you  
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would nearly double the size of the city’s  
central business district; create 4.5 mil-
lion square feet of new commercial, 
institutional, retail, and residential space; 
produce 12,000 permanent jobs; and 
generate more than $100 million annu-
ally in tax revenue.
A joint effort of the city, Yale-New 
Haven Hospital, the School of Medi-
cine, and the Economic Development 
Corporation of New Haven, the plan  
is by all measures ambitious. A $5 mil-
lion federal grant secured by U.S. 
Representative Rosa DeLauro has 
funded the project so far. The cost of 
the plan’s infrastructure, estimated at 
$45 million, will be financed through 
federal, state, and private funding. 
Engineering work for this phase of 
the project has already begun, but it is 
expected to take years to complete.
A private-sector project will 
jump-start the initiative. Winstanley 
Enterprises, a property development 
firm based in Concord, Mass., is ready to 
break ground on a 300,000-square-foot 
office and laboratory “sister building” 
to 300 George Street between the Air 
Rights Garage and College Street in the 
Route 34 right-of-way as soon as the 
state land and air rights are transferred. 
Developer Carter Winstanley, owner of 
300 George, envisions closing Route 
34’s Exit 3, with several lanes of traffic 
rerouted. An existing entrance to the Air 
Rights Garage would remain.
“We are just ecstatic with the vision 
that the downtown will extend to the 
medical center and that we will be a part 
of it,” said Dean Robert J. Alpern, m.d., 
Ensign Professor of Medicine. Alpern 
said the plan addresses two important 
issues: the medical school’s disconnec-
tion from “such a vibrant downtown” 
and its ability to grow. The only limita-
tion on growth in research and clinical 
care is space, he said. 
“We’ve been somewhat landlocked. 
But now, with plans for the conversion 
of the downtown, this will create oppor-
tunities for a lot of new research build-
ings,” Alpern said.
The plan is “going to be a positive 
circumstance for the university,” said 
Bruce D. Alexander, j.d., Yale’s vice presi-
dent for New Haven and state affairs and 
campus development. “We’ve been work-
ing hard whenever we had the opportu-
nity to reconnect the central campus and 
the medical campus. This will be a 
very significant step forward.”
DeStefano said the plan is meant to 
“create a footprint for what happens to 
New Haven over the next 15 years.”
—Charles Gershman
Officials outline plans to 
reconfigure Route 34 
Over the next decade the “highway to 
nowhere” will vanish and be replaced 
by new stores, offices, and homes.
In the 1950s city officials believed that 
New Haven needed a highway link 
to the towns of the Lower Naugatuck 
Valley. The Oak Street Connector, a free-
way extending from I-95 northwest, and 
also known as Route 34, was thought to 
be the answer—but the project was an 
undisputed failure. To clear the way for 
a never-completed segment of highway 
that severed Yale’s medical campus and 
the nearby Hill neighborhood from the 
downtown, 881 families were displaced 
and 350 buildings razed.
Now, more than 50 years after it was 
built, New Haven Mayor John DeStefano 
Jr. has proposed a plan to remove the con-
nector, restore the street grid, and reknit 
the city’s fabric.
The plan, which DeStefano an- 
nounced at an April 20 press conference,  
chronicle news from cedar street
U.S. Rep. Rosa DeLauro and Dean Robert Alpern 
shared a laugh at a press conference on April 20 
to announce the city’s plans to remake the Route 
34 corridor that separates the medical campus 










A new ARRA for science as  
stimulus package boosts NIH 
grants around the country
In his inaugural address in January, 
President Barack Obama pledged to 
“restore science to its rightful place” 
and “not only to create jobs, but to lay 
a new foundation for growth.” These 
goals are intertwined in a $10 billion 
allocation to the National Institutes of 
Health (NIH) in the economic stimulus 
package approved by Congress, officially 
known as the American Recovery and 
Reinvestment Act of 2009 (ARRA). 
The package comes as welcome relief 
to biomedical scientists at the School 
of Medicine and elsewhere who have 
endured years of flat NIH budgets that 
result in de facto cuts after adjusting 
for inflation.
The ARRA moneys provided to NIH 
for “extramural” distribution include 
$8.2 billion for research grants, $1 billion 
to support construction and renovation 
at NIH-funded research institutions,  
and $300 million for the purchase of 
scientific equipment. An additional 
$500 million will support improve-
ments and construction at NIH’s own 
research facilities.
According to Carolyn W. Slayman, 
PH.D., deputy dean for academic and  
scientific affairs, as of June 1 Yale  
scientists had completed more than 
650 ARRA grant applications requesting 
nearly $387 million in support. Those 
grants are in addition to typical nih 
awards, which last fiscal year totaled 
$350 million.
 More than 250 of the ARRA applica-
tions, totaling almost a quarter billion 
dollars, were made under two new NIH 
grant initiatives. Challenge Grants, which 
will account for at least $200 million of 
the stimulus funding, will provide up to 
$500,000 per year for two years, and are 
aimed at what NIH terms “priority areas 
of research,” such as HIV therapy, pain 
management, and health disparities. 
Another $200 million has been assigned 
to Grand Opportunities, or “GO,” grants, 
which are targeted at “high-impact, well-
defined, large-scale” research projects in 
such areas as nanotechnology, genomics, 
and Alzheimer disease.
In addition to providing jobs for 
postdocs, lab techs, administrators, 
and other Yale staff members, Slayman 
says, the ARRA grants will also indi-
rectly, but significantly, stimulate the 
economy by providing revenue and jobs 
to equipment vendors and manufactur-
ers, and to construction firms. Given 
the high historical percentage of Yale 
grant applications funded by the NIH, 
Slayman hopes that a “tsunami” of 
ARRA funds will begin arriving on 
campus this fall.
—Peter Farley
YA LE ,  C IT Y A D D R E SS CH RO N I C D I S E A S E
New Haven is the first U.S. city to participate 
in Community Interventions for Health 
(cih), an international project to address 
chronic disease.
Working with Yale’s Community Alliance 
for Research and Engagement (care), cih 
will study the effectiveness of community 
interventions in reducing the prevalence of 
chronic diseases. In New Haven, high rates  
of obesity put children and minority groups 
at elevated risk for heart disease, type 2  
diabetes, and cancer. 
cih, which works with communities to 
improve health, is spearheaded globally 
by the nonprofit Oxford Health Alliance and 
locally by care, which is part of the Yale 
Center for Clinical Investigation.
“We hope that innovative research con-
ducted at Yale can be translated into vital 
policies and programs to prevent disease and 
promote the health of our citizens right here in 
New Haven,” said Jeannette R. Ickovics, ph.d., 
professor of epidemiology and public health, 
professor of psychology, and director of care.
—John Curtis
E M E RG E N C Y M E D I CI N E A D E PA R TM E NT
The Yale Corporation granted departmental 
status in June to the Section of Emergency 
Medicine, which had been part of the Depart-
ment of Surgery since 1991. Gail D’Onofrio, 
m.d., the current section chief, was named 
chair of the new department.
A faculty committee recommended unani-
mously last fall that the section, which met 
standards for academic and programmatic 
importance, was ready to be elevated to 
departmental status. Emergency medicine 
has emerged as a distinct discipline during 
the past two decades, and 83 percent of all 
emergency medicine programs nationally are 
located within independent departments.
Emergency medicine is now the 28th 
academic department at the school. Since its 
creation as a section, it has grown from five to 
33 faculty members, who have responsibility 
for 72,500 patient visits per year at Yale-New 
Haven Hospital and 21,600 visits annually at 
the Yale-New Haven Shoreline Medical Center 
in Guilford. 
—J.C.















Sight restored with  
artificial cornea
When natural transplants fail,  
ophthalmologists turn to corneas 
made from polymers.
Sixteen years ago, when Awilda Irizarry 
was 33, glaucoma was diagnosed in her 
right eye. Over the years, her vision 
grew increasingly blurry and the pain 
became agonizing. Her doctor pre-
scribed eyedrops to reduce pressure on 
her optic nerve; finally, however, the 
pain was so unbearable that Irizarry 
had her eye removed.
The pain on the right side was 
relieved, but Irizarry began to feel pain 
and lose peripheral vision in her left eye. 
She had four surgeries, including two 
donor cornea transplants, but still her 
vision dimmed and the pain worsened.
“She doesn’t like people to help her 
much,” said Irizarry’s daughter, Maggie 
Morales. “She loves being independent, 
but she was frustrated losing her vision 
little by little. It got to the point where 
she was basically blind.”
Last August, just as Irizarry’s doctors 
were running out of options, Jimmy K. 
Lee, m.d., joined Yale as the new direc-
tor of the cornea and refractive surgery 
sections at the Yale Eye Center. Lee, who 
had just completed a fellowship at the 
Wilmer Eye Institute at Johns Hopkins 
Hospital in Baltimore, came with a clini-
cal interest in corneal transplantation, 
including artificial corneas. After hear-
ing Irizarry’s case history, Lee thought 
Irizarry would be an ideal candidate 
for an artificial cornea transplant. “The 
main indication for an artificial cornea 
is when patients have had multiple 
failed natural cornea transplants,” Lee 
said. “The immune rejection rate is 
much lower because the center is an 
artificial implant.”  
The first artificial cornea implant 
was performed less than 20 years ago, 
after the device was approved for use 
in the United States in 1992. “It was 
uncomfortable for the patient, and there 
were complications,” said Lee, one of a 
handful of surgeons in the country who 
perform artificial cornea transplants. 
The model Lee uses is the Boston K-Pro 
(also known as the Dohlman-Doane) 
developed at Harvard and Massachusetts 
Eye and Ear Infirmary in the 1960s by 
Claes H. Dohlman, m.d., ph.d., con- 
sidered the founder of modern corneal 
science. The K-Pro is made of a trans-
parent polymer that offers a visual 
field almost as wide as that of a normal 
cornea—the transparent part of the eye 
that covers the iris, pupil, and anterior 
chamber and contributes to the eye’s 
focusing power. A donor cornea is used 
as a “peripheral skirt” to provide tissue 
into which the prosthetic implant can 
incorporate itself.
The surgery takes about two hours, 
and the bandages are removed the next 
day. Patients are treated with steroids 
and antibiotics and usually recover 
fully in about a year. Glasses or con-
tact lenses are typically prescribed to 
enhance sight restoration.
It’s always an emotional moment 
when the bandages come off and a 
patient can see again, said Lee, who per-
forms about two artificial cornea trans-
plants per month. “These are patients 
who at best could only see light. After 
the surgery they can dress themselves, 
cook and watch TV again. There aren’t 
many scenarios in medicine where 
there’s such a dramatic change.”
Morales said when Lee removed the 
bandage from her mother’s eye, “she was 
laughing and crying at the same time” 
because she could see her children and 
grandchildren. “It’s better in every way,” 
Morales said. “Now she can see us.”
—Jennifer Kaylin










Ophthalmologist Jimmy Lee is one of a handful 
of surgeons in the country who perform artificial 
cornea transplants. These images show a pa-
tient’s cornea before (top) and after the surgery.
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Nanoparticles loaded with  
siRNAs are new vehicle for 
silencing genes in pathogens
During the past 10 years researchers 
have puzzled over how best to deliver 
small interfering rna (sirna) molecules, 
whose therapeutic value lies in their abil-
ity to shut down genes in higher organ-
isms and in pathogens that may cause 
sexually transmitted infections (stis).
Lipid-based formulations, the most 
widely used sirna delivery vehicles, suf-
fer from certain limitations. In particu-
lar, they are unable to provide sustained 
release of sirnas that may be required 
for many applications, and they may be 
toxic to target tissues.
Now, as reported in Nature Materials 
in May, Yale scientists have found a safe 
and effective way of administering sirna 
molecules. “We wanted to develop a new 
strategy of delivering sirnas with an 
fda-approved material,” said lead author 
Kim Woodrow, ph.d., a postdoctoral fel-
low working with W. Mark Saltzman, 
ph.d., the Goizueta Foundation Professor 
of Biomedical Engineering and Chemical 
Engineering.
For this proof-of-principle work, the 
researchers designed sirnas to target 
a gene expressed widely in the lining 
of the female mouse reproductive tract. 
Saltzman and Woodrow used densely 
loaded nanoparticles made of plga, an 
fda-approved biodegradable polymer, 
to create a stable time-release vehicle for 
delivering sirnas to mucosal tissue.
To convert an fda-approved material 
into an sirna delivery system, the 
particles needed to be small enough to 
penetrate tissue barriers and be taken 
up by cells. These nano sized particles 
also required stable incorporation of 
large quantities of sirna. Saltzman and 
Woodrow demonstrated that their sirna 
nanoparticles were distributed and re- 
tained throughout the female reproductive 
tissue. They also showed that delivery of 
sirna by plga nanoparticles resulted 
in sustained gene silencing in the tissue 
for up to 14 days.
“Before human clinical testing can 
begin, our next step in research will be 
to test this approach directly in disease 
models—for example in the hiv-model 
mice that have an immune system 
genetically identical to that of humans,” 
said senior author Saltzman.
This approach may lead to antimicro-
bial treatments that patients can apply 
themselves. “It is safe and effective, and 
much easier than getting an injection of 
vaccine,” Woodrow said.
—Janet Emanuel
et cetera • • •
$ 4 M I LL I O N FO R STE M CE LL  R E S E A RCH
The state of Connecticut in April awarded close 
to $4 million to Yale scientists to study ways 
in which human embryonic stem cells can 
be used to treat such ailments as spinal cord 
injuries, cancer, and mental retardation. The 
grants were made by the Connecticut Stem Cell 
Research Advisory Committee, formed in 2005 
when the state allocated $100 million over 10 
years to promote such research. Connecticut 
was the third state to pass legislation allocating 
funds for the study of embryonic stem cells.
Five Yale researchers received grants 
worth a total of $2.5 million, and seven others 
received seed grants worth a total of $1.4 mil-
lion. This latest round of funding will support 
such research projects as remyelination of 
nonhuman-primate spinal cords and the use 
of transposons—sequences of dna that can 
change position within the genome of a single 
cell—for genetic manipulation of human 
embryonic stem cells.
—John Curtis
M A R K E R S FO R PRO STATE C A N CE R
Scientists at Yale and the VA Connecticut 
Healthcare System in West Haven have 
reported a link between molecular markers 
and higher death rates from prostate cancer. 
The paper appears in the May 5 issue of the 
Annals of Internal Medicine.
Amidst an ongoing debate in the medi-
cal community over whether screening and 
early diagnosis of prostate cancer save lives, 
or whether the aggressiveness of the tumor 
is more relevant in determining survival, 
the scientists studied tissue from biopsies of 
more than 1,000 veterans diagnosed with 
prostate cancer between 1991 and 1995. They 
found that abnormal expression of the Bcl-2 
gene or of the p53 tumor suppressor gene 
increased the likelihood of patients’ death 
from prostate cancer. 
“Our results expand the current ability 
of clinicians to evaluate the aggressiveness 
of prostate cancer,” said lead author John 
Concato, m.d., m.p.h., professor of medicine. 
“Future research can help to define specific bio-










To deliver small interfering rnas that can silence 
genes, researchers turned to nanoparticles made 
of a biodegradable polymer. The nanoparticles 
were distributed throughout female reproduc-
tive tissue in mice and resulted in gene silencing 
for up to 14 days.
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Genetic Diseases of the Kidney
edited by Richard P. Lifton, m.d., 
ph.d., Chair and Sterling Profes-
sor of Genetics and professor of 
medicine, Stefan Somlo, m.d.; the 
C.N.H. Long Professor of Medicine 
and professor of genetics; Gerhard 
Giebisch, m.d., Sterling Professor 
Emeritus of Physiology; and Donald 
Seldin, m.d. ’43, hs ’46 (Academic 
Press) This book identifies and 
analyzes genetic abnormalities  
causing renal disease in humans.
Principles of Addiction  
Medicine, 4th ed.
by Richard K. Ries, m.d.; Shannon 
C. Miller, m.d.; David A. Fiellin, 
m.d., hs ’95, associate professor 
of medicine; and Richard Saitz, 
m.d., m.p.h. (Lippincott Williams 
& Wilkins) This book blends 
scientific principles underlying ad-
diction with practical essentials of 
clinical addiction medicine to help 
professionals who specialize in 
addiction medicine and who treat 
patients with addiction disorders. 
The Soul of Medicine:  
Tales From the Bedside
by Sherwin Nuland, m.d. ’55, 
hs ’61 (Kaplan Publishing) This 
book is a compilation of stories in 
which more than a dozen special-
ists describe their most memo-
rable patients. The contributors 
also recount instances of fallibility 
and vulnerability that prove that 
doctors are human and caring.
Faith, Hope & Healing:  
Inspiring Lessons Learned From 
People Living With Cancer
by Bernie Siegel, m.d., hs ’61, 
and Jennifer Sander (Wiley)  
In this collection of first-person 
accounts, Siegel brings together 
almost three dozen cancer pa-
tients to share their stories and 
the lessons they have learned 
while living with cancer.
Surgery of the Human Cerebrum
edited by Michael L.J. Apuzzo, 
m.d., hs ’67 (Lippincott Williams 
& Wilkins) This book documents 
advances in surgery on the hu-
man cerebrum during the past 
30 years, bringing together new 
and archival articles to provide 
sources of information on con-
temporary cerebral surgery. 
Handbook of Radiation  
Oncology: Basic Principles and 
Clinical Protocols
by Bruce G. Haffty, m.d. ’84, pro-
fessor (adjunct) of therapeutic  
radiology; and Lynn D. Wil-
son, m.d., m.p.h. ’86, professor 
of therapeutic radiology and 
dermatology (Jones and Bartlett 
Publishers) This handbook covers 
the issues most pertinent to 
patients undergoing radiation 
therapy, including general onco-
logic principles; workup, staging, 
and multidisciplinary aspects of 
treatment; basic principles of 
physics and radiobiology; and 




edited by K.J. Lee, m.d., associ-
ate clinical professor of surgery 
(otolaryngology); and Elizabeth 
H. Toh, m.d. (Thieme New York) 
This handbook uses a bullet-
point format to present an 
overview of the fundamental 
concepts and core techniques 




The dissection photo, now taboo, and its societal implica-
tions are explored in a history of the genre.
During the five decades from the Gilded Age to the Great 
Depression, American medical students created a distinctive 
genre of photograph: the group portrait with cadaver. First 
popularized in the 1880s, these tableaux commemorate the 
experience of dissection—what co-author John Harley Warner 
calls “a harrowing ritual of initiation.” His new book contains 
roughly 200 such photographs.
Warner, chair of the Section 
of the History of Medicine at the 
School of Medicine, describes dis-
section as central to early medical 
education, and yet “transgressive, 
practiced on the social, legal, and 
moral margins.” He analyzes the 
photographs to explore societal 
ambivalence about dissection, 
gender roles, race, class, and the 
iconography of the white coat. 
Warner collaborated with the chief 
curator at the Dittrick Medical 
History Center at Case Western 
Reserve University to collect the 
portraits. These photographs 
proliferated during an era when 
dissection was performed on pau-
pers, executed criminals, and corpses “resurrected” from grave-
yards—bodies that were disproportionately black. Some photos 
convey morbid humor, including pipe-smoking skeletons and 
propped-up cadavers seemingly dissecting a medical student. 
Warner argues that the photographs express a violent 
impulse in early 20th-century society, with such captions as, 
“He lived for others. He was killed for US.” By the mid-20th 
century, bodies used for dissection were increasingly donated 
to medical schools rather than stolen, and the dissection 
photograph became taboo. Today, as Warner notes, even the 
act of dissection is in question: computer simulations may 
















of a Rite of Passage 
in American Medicine 
1880–1930
by John Harley Warner, 
ph.d., Avalon Professor of 
the History of Medicine; 
and James M. Edmonson 
(Blast Books)
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Perez and Brady’s Principles  
and Practice of Radiation  
Oncology, 5th ed.
by Edward C. Halperin, m.d. ’79; 
Carlos A. Perez, m.d.; Luther 
W. Brady, m.d.; et al. (Wolters 
Kluwer/Lippincott Williams & 
Wilkins) This book provides an  
understanding of radiation oncol-
ogy; the physical methods of ra- 
diation application; the effects of 
irradiation on normal tissues; and  
site-specific applications of radia-
tion therapy, either as a single 
modality or as part of a multi-
modality treatment program.
adhd Comorbidities: Handbook 
for adhd Complications in 
Children and Adults
edited by Thomas E. Brown, m.d., 
assistant clinical professor of 
psychiatry (American Psychiatric 
Publishing) This book covers the 
multiple ways in which adhd is 
complicated by other psychiatric 
and learning disorders in both 
children and adults. Clinicians 
will find help for patients whose 
adhd appears in conjunction 
with 11 other syndromes ranging 
from mood disorders to develop-
mental coordination disorder. 
Laryngeal Physiology for  
the Surgeon
by Clarence T. Sasaki, m.d. ’66, 
hs ’73, the Charles W. Ohse 
Professor of Surgery (Plural 
Publishing) This book provides 
an understanding of the three 
principal functional priorities of 
larynx protection, respiration, 
and phonation and features nu-
merous illustrations and tables. 
Most chapters are preceded 
by focused case presentations 
introducing relevant clinical 
descriptions.
Royal Maladies: Inherited  
Diseases in the Royal Houses  
of Europe
by Alan R. Rushton, ph.d., m.d., 
hs ’80 (Trafford Publishing) 
The author provides an histori-
cal study of the effects of two 
hereditary diseases, hemophilia 
and porphyria, on the personal 
and political lives of European 
royal families.
Comprehensive Review  
of Psychiatry
edited by Rajesh R. Tampi, m.d., 
associate clinical professor in the 
Child Study Center; Sunanda 
Muralee, m.d., clinical fellow in 
the Child Study Center; Natalie 
D. Weder; and Heath Penland 
(Lippincott Williams & Wilkins) 
This text will prepare resident 
and practicing psychiatrists for 
all types of standardized exami-
nations, including the Psychiatry 
Resident-In-Training Examina-
tion, the American Board of Psy-
chiatry and Neurology (abpn) 
written exam, and recertifica-
tion exams. The book contains 
2,000 multiple-choice questions 
divided into 10 200-question 
tests, each test covering all 
psychiatry and neurology topics 
in the abpn curriculum. 
The descriptions above are based 
on information from the publishers.
send notices of new books to
Cheryl Violante, Yale Medicine, 
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to cheryl.violante@yale.edu
on campus
E R I C C A M PB E L L
Ubiquitous industry ties have 
risks and benefits 
By the time they’ve reached their 
third year of medical school,  
said Eric G. Campbell, ph.d., vir-
tually all medical students have 
accepted a free meal from drug 
companies. While this treat may 
appear to be a small gift, it could 
also be the first of many that lead 
young doctors and scientists into 
conflicts of interest and the ero-
sion of trust between physicians 
and the public.
“There’s a lot of eating going 
on in academic medicine,” joked 
Campbell, an associate professor  
of medicine (health policy) at 
Massachusetts General Hospital 
and Harvard Medical School, 
who spoke at the Perspectives on 
Medicine series in March.
Relationships between 
industry and academia are not 
necessarily bad, Campbell said, 
noting that the pharmaceutical 
industry underwrites $1.5 billion 
in research each year. “They have 
benefits that are very important,” 
he said. But industry-sponsored 
junkets, along with ghostwriting, 
speaking, consulting, and advi-
sory fees can create the impres-
sion that medical findings are 
“bought and paid for,” he added.
“Managing conflicts of inter-
est is a fundamental part of 
medical professionalism today,” 
Campbell said. “We need to dis-
close these things and we need to 
manage them.”
—J.C.
RO G E R G L A SS
A new vanguard to address 
global health
The fight against disease in the 
developing world has often been 
waged not by public health pro-
fessionals, but by economists, 
politicians, and even military  
personnel, said Roger I. Glass, 
m.p.h., m.d., ph.d., director of  
the Fogarty International Center 
at the National Institutes of 
Health, during a talk at the medi-
cal school in April. Glass spoke  
at the spring symposium of the  
Wilbur Downs International 
Health Travel Fellowship Program.
“It was Colin Powell and 
Madeleine Albright saying the 
health of Africa was a security 
issue,” Glass said, that launched 
the President’s Emergency Plan  
for aids Relief (pepfar). “Global 
health has changed in the last 
10 years,” he said, noting the 
emergence, in addition to pepfar, 
of the Bill and Melinda Gates 
Foundation and the Global 
Alliance for Vaccines and Immuni-
zation, organizations that also 
address health issues in the devel-
oping world. “Global health in  
the 20th century was schools of 
public health and departments  
of international health at medical 
schools. In the 21st century global 
health is more than that. It is  
engineering. It’s business and 
organization of delivery of care.  
It has to do with international  

















A medical student, appalled at what he 
was witnessing, ran from the operating  
room. He was little more than a boy, 
having enrolled at the University of 
Edinburgh at 16, but his revulsion at the 
sight of human blood would stay with 
him throughout his life. That distaste 
was compounded by the horror of sur-
gery before the advent of anesthesia. He 
had to admit to his family that he could 
not follow in his father’s and grandfa-
ther’s footsteps to become a physician. 
But Charles Darwin made a name for 
himself nevertheless.
Marking the 150th anniversary of  
The Origin of Species and the 200th anni-
versary of its author’s birth, an exhibit in 
the Cushing/Whitney Medical Library 
rotunda from February to April explored 
Darwin’s groundbreaking theory in the 
context of the scientific and theological 
beliefs of his contemporaries. From 
Natural Theology to Natural Selection: 
Celebrating the Darwin Bicentenary made 
use of the Historical Library’s own assets, 
including a first printing of the first edi-
tion of The Origin of Species from Harvey 
Cushing’s collection. Toby Appel, ph.d., 
the John R. Bumstead Librarian for 
Medical History, curated the exhibit.
The exhibition opened with 17th-
century texts that sought to reconcile  
scientific discoveries with Christian 
beliefs. John Ray’s Wisdom of God 
Manifested in the Works of Creation is 
an early example of “natural theology,” 
a blending of religion and science that 
still had adherents when Darwin set sail 
for South America in 1831. Also in the 
exhibit is Zoonomia, a medical textbook 
by Erasmus Darwin, grandfather to the 
naturalist. Erasmus Darwin argued 
that organisms inherited useful char-
acteristics, leading to the development 
of higher animals. Though muddled 
with notions about spontaneous genera-
tion and not nearly as well supported as 
Charles Darwin’s arguments, the book 
is a precursor to evolutionary theory.
While Darwin never acquired the 
family passion for medicine, he did 
inherit his grandfather’s curiosity about 
the natural world. During the years 
he studied at Cambridge to become 
a clergyman, Charles Darwin’s true 
enthusiasms were collecting insects 
and attending geology lectures. Not 
surprisingly, a professor recommended 
him for the post of naturalist aboard 
the hms Beagle. The post was unpaid 
and designed not so much to serve 
science as to provide the captain with 
the company of a fellow gentleman on 
the long voyage. Journals and plates 
from the voyage were included in the 
exhibit. The plates—which contained 
capsule
An exhibit at the Cushing/Whitney Medical Library traces the evolution 
of Charles Darwin’s theory.





































new knowledge about plants, animals, 
native peoples, and geology—cemented 
Darwin’s scientific reputation.
Darwin would wait more than 20 
years to publish The Origin of Species. 
He wanted first to increase his own 
knowledge and come up with a coherent 
theory. He may also have been reluc-
tant—he knew his findings would put 
him at odds with both the religious and 
scientific establishments. Stress over his 
concerns, some biographers speculate, 
may have caused Darwin’s chronic head-
aches and cramps. He found relief in the 
“water cure” many Victorians took for all 
manner of complaints. A text on the cure 
was among the items on display. 
Darwin was finally pushed toward 
publication when he learned that the 
naturalist and explorer Alfred Russell 
Wallace had developed a strikingly simi-
lar thesis. Friends of Darwin arranged 
for the joint publication of the Wallace 
and Darwin papers, and Origin followed. 
Within two decades, most of the sci-
entific community accepted Darwin’s 
theory of evolution, though debate 
about natural selection stretched on 
for decades.
Darwin’s landmark contribution to 
science—and the ongoing controversy  
it stirs in some circles—made the 
anniversary year a major public event.  
At Yale, it was observed throughout 
the campus. This spring and summer, 
the Peabody Museum took passengers 
aboard a wooden schooner to simulate 
the conditions on the hms Beagle.
Colleen Shaddox is a freelance writer in 
Hamden, Conn.
o pp o site ,  lef t  Charles Darwin in a por-
trait by John Collier from 1881. The year 2009 
marked the 200th anniversary of his birth and 
the 150th anniversary of the publication of his 
landmark The Origin of Species.
o pp o site ,  r i ght  On Santa Cruz in the 
Galapagos Islands, a crab climbs over volcanic 
rock to escape the pounding waves. Darwin’s 
observations of the differences in flora and 
fauna in the islands of the Galapagos archi-
pelago led him think about how life evolved.
abov e  Among the Medical Historical Library 
collection is a first printing of the first edition 
of The Origin of Species, published in 1859.  
Darwin’s ideas have held up and provide a 























Center Director Lars Brandén 
became hooked on gene therapy 
after reading a science magazine 
in his native Sweden. He has done 
research at that country’s Karo-
linska Institute and at Columbia 
University. 
12
Lars Brandén and his colleagues at the Center for High Throughput Cell 
Biology are the first scientific team to occupy space at West Campus. 
Others will follow in the coming years.
Pioneering the West Campus
13
As an 11-year-old in Sweden in 1979, Lars Brandén read about 
retroviruses in a popular science magazine, and it occurred to 
him that they could introduce healthy genes into cells. “I told my 
father I would do gene therapy when I grew up,” he said, laugh-
ing. “When you’re 11 years old, you don’t know. But I did.”
Now director of the Yale Center for High Throughput 
Cell Biology, Brandén, 41, has kept that promise, and moved 
on to another frontier of genetic research, in keeping with his 
propensity for exploration and individualism. He wears his hair 
long and has been known to sport a handlebar mustache. The 
Thor’s Hammer around his neck is a replica from the era of an 
ancestor who was a henchman of a 12th-century Norse king. 
He smokes cigars and feeds the piranhas in the tank in his 
office with meat on a string.
That office is on the West Campus, where Brandén and 
his colleague James E. Rothman, ph.d., professor and chair 
of cell biology, Wallace Professor of Biomedical Sciences, and 
executive director of the center, run the first laboratory to move 
into the 1.6-million-square-foot former Bayer facility, which 
Yale purchased in 2007. The center is housed in a building 
just inside the West Haven town line, a few hundred feet from 
the tiny Oyster River. In the lobby is an old-fashioned popcorn 
wagon, a coffee table that used to be a packing crate for lab 
instruments, and a large photograph of 16 smiling scientists. 
Apart from several staff members from the Peabody Museum, 
these 16 people are the first Yale researchers to colonize the 
West Campus. There, in the first of three core science facilities 
planned for the West Campus, they are quietly performing 
genetic research on a scale that beggars the imagination.
Starting from scratch 
When Brandén and the team arrived at Building B-31 on 
the West Campus in July 2008, they started from scratch. 
“Not even the toilets were working. … We had to buy pens, 
even. We had no phones—nothing,” he says. The rooms 
were then gutted and painted, data jacks were installed, 
and the researchers began placing orders for the most state-
of-the-art equipment available: automated liquid and plate 
handling platforms, an Opera confocal imaging system, 
a 24-cpu Linux computer cluster, and many other items, 
some of them custom-built.
But Brandén is used to being the first man in a new 
environment. The Center for High Throughput Cell Biology 
is the third such infant facility he has joined. In 1995, he was 
one of the first scientists to work at the new southern campus 
of the Karolinska Institute, just outside Stockholm. There he 
kept his childhood vow by studying gene therapy while earning 
his doctorate in cell and molecular biology. Several years later 
he helped design and set up Columbia University’s Genome 
Center and its high-throughput chemical compound screening 
facility, at which he served as associate director until last sum-
mer’s move to Yale with Rothman and several other colleagues. 
Brandén’s experience in New York made the setup  
process faster. Whereas the Columbia institute took some 
18 months to get up and running, Yale’s was ready in 13, even 
though it is a more complex operation. 
Perhaps unsurprisingly for a man who takes pride  
in his Viking ancestry and sometimes hunts his own food 
with bow and arrow, Brandén relishes the role of pioneer.  
By Jenny Blair















At a new campus, he said, one has “freedom to explore novel 
approaches for doing science without having a preconceived 
idea as to how it should be done. [It gives] you more freedom 
to define what direction you want to go in yourself instead of 
having to battle old fiefdoms.”
First teams to use the core
Daniel DiMaio, m.d., ph.d., vice chair and Waldemar Von 
Zedtwitz Professor of Genetics, and his team are among 
the first Yale scientists to make use of the center’s services. 
Brandén’s group helps researchers learn how cellular processes 
unfold by examining the function of every gene in the human 
genome more or less at once. In each of thousands of tiny 
adjacent wells, a different gene is deactivated to determine how 
cells react. Laser microscopes scan the wells and send data to 
computers with between 10 and 80 terabytes of disc space. The 
final result is an inventory of genes that may be important to 
the cellular process being studied as well as information about 
the pathways those genes may affect, loaded on a jump drive 
that fits on a researcher’s key ring.
DiMaio and graduate student Alex Lipovsky study the 
human papilloma virus (hpv), 13 of whose 130 types can cause 
genital warts and cervical cancer. The researchers are inter-
ested in the crucial first steps of infection: how the virus enters 
human cells and expresses its genes. All hpv types consist of a 
protein shell around a length of dna that encodes between six 
and eight genes. Human cells and the virus’ protein coat inter-
act in such a way that the cells allow the virus to enter. The cen-
ter is working with DiMaio’s team to design an assay to pinpoint 
the cellular genes involved in this event. Lipovsky began by cre-
ating a pseudovirus whose protein coat is identical to hpv’s but 
whose innards contain only a gene encoding a green fluorescent 
protein. This stand-in for the real virus is later mixed with cells 
in which one gene has been selectively deactivated.
The experiment takes place in tiny volumes and huge 
numbers. Within the center’s labs are machines that hold 70 
plates, each plate containing 384 wells a few millimeters in 
diameter and holding 50 microliters each. Robots inject 1,000 
human cells into each well. Then “bullets” that knock out spe-
cific genes are introduced: small interfering ribonucleic acids, or 
sirnas. These short lengths of rna, discovered 10 years ago in 
plants, are now available in synthetic form, several for each gene 
in the human genome. The sirnas effectively disable the gene 
in question—a different gene in each well—and are available to 
researchers in vast libraries. The sirnas are mixed with the can-
cer cells for 48 hours; then the pseudovirus is introduced.
Cells that take up the pseudovirus glow green. Some 
cells take it up less effectively than others, and some never take 
it up at all. A cell that doesn’t glow either did not take up the 
virus, prevented viral transit to the nucleus, or failed to express 
the green fluorescent protein or express the virus—and that 
is important, since it may mean the specific gene silenced in 
that well by that sirna is critical to virus uptake or gene expres-
sion. Those variations in the brightness of the green glow—the 
range of fluorescence—are examined, quantified, and sorted 
out by the automated microscope and software, leading to hits 
that may be crucial genes in the process of hpv infection. 
DiMaio’s group of researchers will then go on to study the 
candidate genes in their own lab.
Though suppressing genes to see how that alters cell 
behavior sounds straightforward, Lipovsky said that “the devil 
is always in the details.” There are countless technical steps 
that must be refined to perfection before the assay can be run, 
and it takes months of planning to hash them out. How long 
and at what temperature should the cells be incubated? How 
should the growth medium’s greater viscosity at the edges  
of the plates be accounted for? Many commercially available  
sirnas have never been tested—will they do their job and 
knock out the genes? The center takes pride in its ability to 
guide researchers through these complex questions of experi-
mental design. For several months Lipovsky spent several 
days a week driving to West Campus and meeting with assay-
development specialist Michael Wyler, m.a., also formerly of 
Columbia, to discuss these details.
This kind of collaboration with clients, Brandén says, 
sets the Yale center—which charges both Yale investigators and 
outside parties a fee for service to cover some of its costs—apart 
from many of its competitors. At another university that offers 
high-throughput sirna screening, he said, “referring investiga-
tors have to come and do the screens themselves. So you have 
access to instrumentations, and access to the facilities, but basi-
cally, you’re also inviting everyone to do the same mistake over 
and over again. ... We have a different approach, we’re taking the 
investigator here, we work with him to help him develop their 
assay, then we run it for him.” Wyler added that the approach at 
Yale is both fun and science-oriented. “We actually interact with 
the PIs, sit down, have science conversations, plan out the assays 
correctly, and work with them from the beginning to the end.” 
Pioneering the West Campus
In his lab at West Campus, Lars 
Brandén (right) looked over results 
with Leena Kuruvilla, Susanne 
Hasse, and Michael Wyler.
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“You can definitely feel the enthusiasm. With this 
screen, we’re getting an integrated picture of how [hpv] infects 
the cell,” said Lipovsky. “And this has never been done before.”
A revolution in high-throughput screening
High-throughput screening (hts) technology, which can also 
employ chemical compounds rather than sirnas to knock 
out genes, was developed in the late 1980s and has since 
been a mainstay of drug discovery within the pharmaceutical 
industry. Only in the last 10 years has the technique moved 
to academia on an industrial scale. Yale is joining the wave of 
academic institutions to institute hts capacity; other pioneer-
ing groups include the Broad Institute of the Massachusetts 
Institute of Technology and Harvard, and Stanford’s High-
Throughput Bioscience Center. 
Relying as it does on complex and costly robots, laser 
microscopes, and vast computing power, hts might be thought 
of as research on a scale appropriate to the spectacularly com-
plicated workings of the cell. A cell’s machinery comprises 
a series of chemical signals that, like a microscopic Rube 
Goldberg contraption, each set off a different process that cas-
cades toward an end result. Unlike a Rube Goldberg gadget, 
though, these signals proceed across intricate networks rather 
than linearly.
Teasing out how each gene product interacts with the 
next one has historically taken years; to date researchers have 
pieced together only small parts of human cell networks. Most 
previous methods relied on chemical compounds alone to 
knock out one part of a cellular process. But the chemicals can 
deactivate more than just the process in question, complicating 
the analysis. “All drugs like that are dirty ... which made it very 
cumbersome to delineate,” said Brandén. The tidy specificity 
of sirnas—their ability to deactivate a single gene—is part 
of what has allowed the hts revolution to take place. Also, 
advances in automation and computing now allow thousands 
of experiments to occur within a day. The rich lodes of data 
from an hts assay can be examined by advanced software for 
hits, or promising results. Many of the hits lead nowhere, but  
a few will point the way to genes or other compounds that are 
important to the process being studied. Gradually, a network  
of intracellular interactions becomes clear and can be mapped 
out graphically on powerful computing platforms. And once 
those networks are understood, scientists can begin to design 
drugs for tweaking them.
The frontiers so far seem limitless. Once one cell type’s 
networks are understood, the researchers can explore those of 
related cell types to pinpoint important differences. Genetic 
variations will lend yet another dimension to the hunt. “If you 
understand the differences,” said Brandén, “then you can also 
understand the side effects of drugs, how diseases are pro-
gressing in different tissues, and why they behave as they do.”
With dozens of cpus crunching the data—and the cen-
ter is able to tap up to 1,000 more at Yale’s High Performance 
Computing cluster in downtown New Haven—the sheer scale 
of the work is breathtaking. But the size of the human genome 
makes it necessary. After a half-century of research, only about 
one-tenth of the human genome’s function is understood. 
Some 20,000 to 25,000 genes are thought to exist, but how 
they and their protein products interact is still largely a mys-
tery. High-throughput screening speeds up discovery by orders 
of magnitude. Currently, the center has the instruments to run 
experiments on 200,000 wells per day, but that level of pro-
duction would need a team many times the size of the present. 
As part of the center’s long-term plans, Brandén expects 
to design several hundred such cell-based assays that will allow 
an exploration of the entire human proteome. “If you cover  
the whole proteome, you can then get supremely detailed 
information about any unknown gene. You can profile drugs 
to understand what they would do on a global level.” This 
approach would vastly reduce the number of animal subjects 















Pioneering the West Campus
The scientists and staff of the Yale 
Center for High Throughput Cell 
Biology come from a variety of 
backgrounds. Center director Lars 
Brandén is from Sweden and his 
team includes a former firefighter 
from Arkansas, a computer scientist 
from the Ivory Coast, and an 
informatics director who raises 
carnivorous plants. 
Back row, from left: Steve Berman, 
Phil Williams, Marie-Aude Guié,  
Laurie Tomei, Lori Ortoleva-Donnelly, 
Lars Brandén. Front row, seated; 
Leena Kuruvilla, Yan Song, Adrian 
Poffenberger, and Susanne Hasse. 
Seated on ground: Michael Wyler 
and Jason Ignatius. Not pictured: 
James Rothman, Deborah Smith, 
Trisha D’Errico, and Michael Richo.
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happening before you go there. You can direct the efforts of 
medicinal chemistry.” 
The center will try to break even and it is run as a busi-
ness. A small, early investment allowed Brandén to hire a 
marketing company and contact cell biology investigators in 
academic and industry centers around the world, thus creating 
a targeted database of potential customers. 
The Center for High Throughput Cell Biology is a 
model for two other core research facilities planned for West 
Campus. A second facility will provide gene-sequencing ser-
vices, and will be led by Richard Lifton, m.d., ph.d., chair and 
Sterling Professor of Genetics. The third group, which will 
perform high-throughput screens of drug-candidate chemical 
compounds, will be organized and overseen by Craig Crews, 
ph.d., professor of molecular, cellular, and developmental biol-
ogy. Thanks to the campus’ vast size and resources, the three 
cores, expected to be up and running by December, will boast 
an information-gathering capacity rare in academia. 
And the cores in turn will support departments and 
programs across the university, including five new interdisci-
plinary research institutes: the Institute of Cell Biology, also led 
by Rothman; and institutes of chemical biology, cancer biology, 
microbial diversity, and systems biology. Like the Center for 
High Throughput Cell Biology, these institutes will comprise 
groups of researchers from across the sciences, including 
engineers, chemists, geologists, and forestry experts as well as 
biologists of every stripe. “The strong sense of the science com-
munity at Yale and elsewhere is that it is going to be important 
to mix up these disciplines a little bit. There will always continue 
to be really strong science coming out of the core disciplines, but 
the most exciting opportunities might lie at the intersections 
[of different disciplines],” said Michael J. Donoghue, ph.d., vice 
president for West Campus planning and program development. 
“One of the ways that the West Campus can be useful is to break 
down those barriers by actually co-locating people from those 
different disciplines. It provides an opportunity to do something 
you can’t really physically do on the central campus.”
The wild, wild West Campus
In keeping with that wild West Campus culture of diversity, 
the center’s team members have a broad spectrum of training, 
backgrounds, and interests. (They also hail from several differ-
ent countries; their potlucks, featuring international cuisine, are 
reportedly superlative.) Bioinformatics investigator Phil H.  
Williams, ph.d., grew up in Horseshoe Bend, Ark., where he 
worked as a volunteer firefighter and helped his father run a 
lawnmower-repair business. After his father bought an ibm 386 
to keep track of inventory, Williams was hooked, developing a 
deep fascination with computers. He eventually left Horseshoe 
Bend and studied bioinformatics at the University of Arkansas. 
Research informatics scientist Marie-Aude Guié, m.s., is a com-
puter scientist who hails originally from the Côte d’Ivoire. She 
puts up with good-natured teasing about being a princess, as 
her father is king of their ethnic group, the Baoulé, in her home 
country. Ashima Bhan, ph.d., is the team’s cell culture biologist 
and has a background in toxicology. Informatics director Adrian 
Poffenberger, m.s., who grows carnivorous plants in his office, 
has studied biology, mathematics, and cheminformatics, and has 
14 years’ experience in drug discovery research.
With researchers of such disparate backgrounds bring-
ing their ideas to the table, “intense brainstorms” are the norm, 
and Brandén says team meetings are a lot of fun. “We’ve had 
more positive science interactions in the last six months here 
than we had over four years at Columbia,” he said. (The tran-
sition from New York to suburbia also appears to have gone 
relatively smoothly. Brandén has a house in the Woodbridge 
countryside where he barbecues on his riverside deck, while 
Wyler, formerly a Brooklynite, says he likes being able to drive 
to work and park in front of the building.)
The center’s hts assays hold the potential to reveal more 
information about cells and in greater detail than has ever been 
possible at Yale. hts, said Lipovsky, is itself a marker of a shift 
toward greater complexity in science. “If we’re to make the next 
leaps in science, we need to understand not only how genes 
work by themselves, but also how they work together,” Lipovsky 
said. “We need to understand processes, not just genes.” He 
is excited not only for the hpv results that will come from his 
carefully designed assay, but also to be a part of the center’s 
maiden voyage. After all, he said, “the reason I’m in science is 
to pioneer things.”
For his part, Brandén says he is in the perfect job. “I’m 
dying to know things,” he said. “I’m a very curious kind of per-
son.” With high-throughput screening, “you’re exposed to new 
science every single project that you run. And the allure of visu-
alizing and understanding a complete transduction network—
not only one pathway, but the global one—that is intense.”
Jenny Blair, m.d. ’04, is a writer and physician in New Haven.
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A medical profession that began in the 1960s has 






As did the first physician associates, 
Gabriel Rocha started his route to 
medicine in the military. As a U.S. 
Army medic based in Baghdad, 
Rocha treated many of those 
injured when the United Nations 
headquarters were bombed in 2003. 
After leaving the army, Rocha came 
to Yale for training as a physician 
associate. While at Yale, he was 
inducted into the U.S. Navy, where 
he will serve upon his graduation.
In 2002, a year after graduating from high school in Brigham 
City, Utah, Gabriel Rocha enlisted in the U.S. Army. He 
decided to become a medic, in large part because the position 
included airborne training and he thought the idea of jumping 
out of planes sounded adventurous and exciting. But it wasn’t 
long before he got to see what a medic’s job is really about. 
In 2003, the United Nations headquarters in Baghdad was 
bombed; many of the casualties were brought by helicopter to 
the aid station where Rocha was deployed.
“People had been dug out of the rubble,” he recalled. 
“There were burns, shrapnel injuries, blunt force trauma, and 
head injuries.” The number of wounded was so overwhelming 
that even the senior medics were treating patients indepen-
dently, along with the doctors and physician assistants. 
Rocha worked closely with the pas—as physician assis-
tants have been known since the mid-1960s, when their profes-
sion was born—as well as doctors. “Basically, you couldn’t tell 
the difference between them, that’s how knowledgeable and 
professional the physician assistants were,” he said. That event, 
like so many others, combined with the daily occurrence of 
treating Iraqi civilians—including many children—who came 
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to the aid station for care, convinced Rocha that he wanted to 
pursue a career as a pa. 
“When I joined the military I wasn’t thinking at all about 
the health care field, but then I saw how rewarding it was, taking 
care of patients and helping people,” Rocha said. “Becoming a pa 
just seemed like the most direct and efficient way possible to get 
to do what I wanted to do, which was help others.” 
Rocha, who is in his second year of Yale’s 28-month 
Physician Associate Program, is following a trail blazed almost 
40 years ago by a previous generation of former military per-
sonnel who used medical experience acquired on the battlefield 
as a springboard to a civilian career in health care. (Although 
the preferred term is physician assistant, the Yale program uses 
the term physician associate.)
A new program fills a gap
The physician assistant profession began at Duke University in 
1965; it was originally designed to train assistants who could 
relieve the burdens of overworked general practitioners. In the 
early 1960s, the Graduate Medical Education National Advisory 
Committee had issued a report that identified a shortage of 
primary care providers in rural and underserved areas. It was 
thought that physician assistants could help fill that gap. 
At the same time, the nascent profession quickly pro-
vided an opportunity for medical corpsmen returning from 
Vietnam to find a civilian application for their battlefield 
experience. During the war, about 30,000 men with medical 
experience were being discharged each year; of those veter-
ans, 6,000 had extensive medical training. 
“These guys saved lives and made tremendous sacri-
fices,” said Alfred Sadler Jr., m.d., who served with his twin 
brother, Blair, as founding co-director of Yale’s pa program, 
which began in 1971. “It was a way to show our appreciation 
and to help them assimilate into civilian life.”
Sadler said the birth of this new medical profession was 
also aided by a national mood of openness toward progres-
sive solutions to social problems. “We encountered no real 
obstacles to what we’d set out to do,” Sadler recalled. “The late 
’60s and early ’70s was a time of great innovation in health 
care in the United States.” Noting the creation of the National 
Health Service Corps in 1972 and President Lyndon Johnson’s 
Great Society initiative, which had established Medicare and 
Medicaid in 1965 and 1966 respectively, Sadler said “there was 
a willingness to experiment with new health care models.” 
Alfred Sadler Jr. and his twin broth-
er, Blair, were co-founders of Yale’s 
Physician Associate Program in 
1971. The young program offered an 
opportunity for medical corpsmen 
returning from Vietnam to apply 
skills learned on the battlefield to  
a civilian setting. 
Nurse Ann Bliss helped launch 
Yale’s Physician Associate program 
and also worked to set national 
standards for the profession. Yale’s 
was one of the first programs to set 
a full-fledged curriculum so that 
students would leave, Bliss said, 
with “clinical skills and acumen.”
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Yale’s program got its start when Jack Cole, m.d., then 
the chair of surgery, received a trauma training grant from 
the Commonwealth Fund, a private foundation dedicated to 
improving the health care system. Sadler, who, along with 
his brother, a lawyer, had written the original 911 emergency 
dispatch legislation and created the region’s emergency medi-
cal service infrastructure, thought pas would be ideally suited 
to emergency medical care. (In 1968 the Sadler brothers also 
drafted and helped implement the Uniform Anatomical Gift 
Act, which governs organ donations in all 50 states.) As direc-
tor of Yale’s trauma program within the Department of 
Surgery, Sadler convinced Cole to use the grant money to cre-
ate a pa program—or, as he put it, “the medical school’s first 
experiment in non-physician education.”
Almost four decades later, Sadler calls the experiment 
“a tremendous success.” The numbers would seem to support 
the growing popularity and acceptance of pa programs glob-
ally, as well as at Yale. In 1973, Yale graduated five students 
who received a certificate in physician associate studies. Since 
then, Yale has graduated 895 physician assistants. Nationally, 
77,000 pas are practicing in virtually all medical specialties, 
including surgery. There are now 145 accredited pa programs 
in the United States, with a growing number in foreign coun-
tries, including the United Kingdom, Canada, Japan, and many 
African countries studying the American pa model with an eye 
toward implementing something similar.
Setting the standards
Ann Bliss, r.n., m.s.w., was part of the team that launched 
Yale’s pa program and established national guidelines and stan-
dards. “When we got started,” she recalls, “not many leading 
medical schools had taken this up.”  
She said the architects of Yale’s pa program set two basic 
rules: “One was to take college graduates.” The second rule was 
that “It had to be equal. We didn’t want anyone saying nursing 
is for girls; medicine is for boys.” They also set out to create a 
program that would produce leaders in the new profession, in 
keeping with Yale’s mission as a university.
The founders were determined to create a challenging 
course of study with both didactic and clerkship components. 
“We were one of the first programs to launch a full-fledged 
curriculum,” Bliss said. “We didn’t want our students to gradu-
ate without acquiring clinical skills and acumen.”
The other important ingredient for success, Bliss said, 
was accepting students who embraced the philosophy of the pa 
program. Bliss was responsible for evaluating each applicant’s 
psychological readiness. In addition, “I watched their backstage 
behavior. For instance, were they rude to the secretaries?” she 
said. “We wanted people who would take a more humanist 
approach to patient care, who were team players,” and who 
would work well with the doctors.
The curriculum established by Bliss and the Sadler 
brothers—a nine-month didactic phase followed by 15 months 
of clinical rotations resulting in a pa certificate—remained 
the same until the late 1990s. In 1995, students approached 
Lawrence S. Cohen, m.d., hs ’65, then special advisor to the 
dean, requesting that Yale pa graduates receive a master’s degree 
instead of a certificate. They argued that by offering a degree, 
Yale would be able to compete for the top students and that a 
Yale degree would in turn improve the graduates’ job prospects.  
Cohen raised the issue with David A. Kessler, m.d., j.d., 
when Kessler took over as medical school dean in 1997. The 
new dean appointed a committee led by Walter Kernan, m.d., 
professor of medicine, to review the program. “The pa program 
had been a bit under the radar at the institution for a number 
of years,” Kernan said. “It was doing a great job of training pas, 
but its visibility in the larger academic community of the medi-
cal school wasn’t high, because it had never been fully inte-
grated into the training of medical students and residents.” 
The committee found that Yale was in the minority in 
giving its pa graduates certificates rather than degrees. “But we 
decided we didn’t simply want to grant a degree to get the best 
students,” Kernan said. “We wanted to grant a degree only if 
the curriculum warranted a graduate degree.” 
After a thorough analysis of the curriculum, includ-
ing comparing it to the curricula of the university’s nursing, 
medical, and graduate schools, the committee determined that 
with certain changes, a Yale pa education would be worthy of 
a master’s degree. Their main suggestion was that pa students 
should be required to write a thesis like their medical school 
counterparts. The program wasn’t long enough for students to 
conduct independent research and analyze the results; however, 
they could produce a finished product comparable to a biomedi-
cal research grant application. 
The other recommendation was that the medical school 
had to take more ownership of pa training. “At the time we 
met, it was common practice for the pa students to get their 
training away from campus and away from Yale-New Haven 
Hospital at other hospitals and community practices,” Kernan 
recalled. “We felt that the faculty of the medical school needed 
to be more engaged in the teaching of these students.”
After the committee’s recommendations were imple-
mented, the program grew in length to 25 months to give 
students time to write a thesis, and students began doing 
their clinical rotations alongside medical students at Yale-
New Haven Hospital. In addition, it became a requirement 















appointment in the medical school. Directed by Associate 
Dean Mary Warner, m.m.sc., pa-c, the pa program is under 
the umbrella of the medical school, with academic oversight 
from the deputy dean of education and administrative oversight 
from the medical school dean. Starting in 1999, pa graduates 
began receiving a full master’s degree.
Kernan says that the move from granting a certificate to 
conferring a degree was a necessary next step in the program’s 
coming of age. “I heard from some pa students just recently,” 
he said. “They said that if Yale were not granting degrees, they 
wouldn’t have come here.” 
Another milestone for the pa program came in July 
2003, when the national Resident Review Committee (rrc) 
mandated that resident physicians be held to an 80-hour work 
week. “We went into crisis mode,” said Robert Udelsman, 
m.d., m.b.a., the William H. Carmalt Professor of Surgery and 
Oncology and chair of the Department of Surgery. “If residents 
were held to an 80-hour work week, there was no way we could 
comply with our then-workload, which has since tripled.” 
The solution? More pas. There were two full-time pas 
on surgical services before the rrc mandate; now there are  
26. “It’s been extraordinarily successful,” Udelsman said.  
“It basically solved the crisis.” Beyond that, Udelsman says 
the presence of pas to help with floor management of patients 
has benefited the physicians as well as patients. “The pas are 
here long term, whereas the residents cycle through,” he said. 
“The pas have played an incredibly important role in stabilizing 
services. They are fully integrated into our patient care model, 
and without them we could not function at the level that our 
patients and their families deserve.” 
The most recent change in the pa program, which went 
into effect a year ago, was to extend it from 25 to 28 months. 
The three extra months were added to the didactic phase to 
enable instructors to cover all the material that is now required. 
“We found it increasingly difficult to cover all the mandated 
topics,” said pa Program Director Warner, “and we also wanted 
to reduce the stress on our students and give them enough 
time to participate in the Yale community.” 
Assistant v. associate
Yale may have joined the majority of pa programs a decade ago 
in offering a master’s degree, but it has remained resolutely 
independent when it comes to the name of the Yale program—
for reasons that run deeper than mere tradition. In the early 
days, more than half the pa programs nationally were called 
physician associate programs, but as time went on, the pre-
ferred term became physician assistant, which is the term used 
by the American Medical Association (ama). 
“It comes up for debate within the profession every five 
years or so,” said Warner, “But we feel that assistant sounds 
hierarchically lower and that associate is a more accurate reflec-
tion of the pa’s role with respect to patients and physicians. 
Our program is called physician associate, because that’s what it 
was called when it started, and I’m not changing the name; the 
alumni would revolt.”  
But this debate enters into a deep current that runs 
through the profession—one that seeks healthy relation-
ships between men and women, care and cure, colleagues 
and subordinates.  
From the outset, there were those who questioned the 
need for another allied health profession. After all, nurses, 
a known quantity to both physicians and patients, had suc-
cessfully been carrying out many of the same functions for 
years. Indeed, as early as 1969, the ama had held discussions 
with the American Nurses Association about the possibil-
ity of nurses becoming physician assistants. The women’s 
liberation movement was starting to resonate with profes-
sional women, however, and the nurses emphatically rejected 
the proposal for fear that they would become handmaids of 
patronizing male physicians. That refusal to broaden the 
scope of their practice led directly to the creation of the new 
midlevel profession of physician assistant, which was largely 
male-dominated in its beginning. 
The profession of nurse practitioner was established at 
around the same time as the pa program; however, the two 
programs have different curricular emphases, according to 
Warner. “We emphasize medical sciences in pa training, simi-
lar to the medical school model,” she said, “whereas advanced 
practice nursing emphasizes integration of the physical and 
psychosocial assessment, health promotion, and disease man-
agement. Another difference in the two professions is that pas 
work with physician supervision while nurse practitioners may 
opt for independent practice in many parts of the country. ” 
When the pa program got started, the majority of stu-
dents were military veterans, but as time has passed the profes-
sion has become feminized as women have turned to it as a 
way to strike a balance between a meaningful career in health 
care and family life. 
Warner, who became a certified pa in 1992, is one 
such woman. She had planned to become a doctor since she 
was a child of 10. After college, she worked for two years in 
a health care environment to gain some experience and pay 
off student loans. It was then that she met her first pa and 
became intrigued. She began to weigh the years of medical 
training required to become a physician against her desire 
to raise children and decided that becoming a pa was the 
better route to take.
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“I thought this would be a very efficient way to do a lot 
of what I love without having to turn off or postpone the rest 
of my life,” she said. Has it been a good decision? “Absolutely.” 
The added plus, which Warner didn’t foresee when she started 
out, is that unlike medical students, who must choose a spe-
cialty, pas train in a generalist model. That means that they can 
move from one specialty to another with on-the-job training 
from a supervising physician. 
After getting her pa degree from Emory University 
School of Medicine Physician Assistant Program, Warner 
worked in orthopaedic surgery for three years. Then she 
switched to cardiac surgery for five years before returning to 
orthopaedic surgery. When she came to Yale, she worked in 
emergency medicine.
Mathew Simmons, m.m.sc., pa-c ’06, went so far as to 
apply to and get accepted by a medical school, Florida State 
University College of Medicine, before deciding to become a 
pa instead. “The summer before my senior year, I volunteered 
in an operating room at a local hospital,” Simmons recalled. 
“The whole time I didn’t feel great about medical school. 
Then I got engaged and realized I wanted to put my family 
and home life first. My stepdad is a doctor, so I know how 
much you have to sacrifice.” 
Simmons, who works in a gastroenterology practice  
in Florida, has no regrets about not going to medical school. 
“I still have plenty of responsibility, and I take care of patients 
every day,” he said. “It’s very challenging and intellectually 
stimulating.” The only downside, Simmons said, is the fre-
quently asked question, ‘Are you going to go on and become a 
doctor?’ “I have to tell them, no, that’s not how it works. It’s a 
little annoying, but you get used to it.”
According to Warner, about 92 percent of Yale’s pa 
students receive some form of financial aid, compared to 83 
percent of medical students. “If you look at who we train, our 
students have smaller parental contributions with less money, 
so time and money are important factors.” 
Warner said many people who apply to become pas are 
looking for second careers. Thea Cogan-Drew, who enrolled in 
Yale’s program in 2007 and will graduate in December, worked 
as a photographer, graphic designer, and art director for several 
years before she “hit a plateau,” and began looking for a more 
satisfying career.
“I explored a lot of career options before coming to 
medicine,” she said. “Then, based on where I was in my life 
During her tenure as director of the 
program, Mary Warner has overseen 
an expansion of the program from 
25 to 28 months. The additional 
three months allow instructors to 
cover all the didactic material that  
is now required.
personally and professionally (she is the mother of a 4-year-
old son and pregnant with her second child), I decided that 
the pa degree was the best route for me, as opposed to medi-
cal school.”  
The National Commission on Certification of Physician 
Assistants estimates that pas do 80 to 90 percent of what 
physicians do but bill at 15 percent less. As the nation grapples 
with ways to overhaul the health care system to make it more 
accessible and affordable, many people see an expanded role 
for physician assistants as a key part of the solution. “From the 
country’s point of view, it’s an incredibly important program,” 
said medical school Dean Robert J. Alpern, m.d., Ensign 
Professor of Medicine. 
“Access to cost-effective care is who we are,” said John 
Bond, pa-c ’76, who has worked as a pa in Vermont since his 
graduation. “We’re talking about people who are interested in 
providing care to patients in underserved areas and training 
those people in less time and at a lower cost. What isn’t there to 
like about what pas can do in this time of health care crisis?” 























MS expert named to 
head neurology
davida.hafler,m.d., a 
leader in multiple sclerosis (MS) 
research, was named chair of neu-
rology at the School of Medicine 
and chief of neurology at Yale-
New Haven Hospital, effective 
September 1.
An expert on the mechanisms 
of autoimmunity and inflam-
matory diseases of the central 
nervous system, Hafler was direc-
tor of molecular immunology in 
the Department of Neurology 
at Harvard Medical School and 
an associate member of the 
Broad Institute of Harvard and 
mit. He was the Jack, Sadie, and 
David Breakstone Professor of 
Neurology (Neuroscience) at 
Harvard Medical School, and 
a neurologist at Brigham and 
Women’s Hospital.
Hafler’s recruitment comple-
ments ongoing research at Yale 
in neurology, genetics, and trans-
lational immunology. Hafler will 
build upon existing neurology 
research in such areas as spinal 
cord injury and repair, epilepsy, 
and neurodegeneration, and he 
will expand research in MS and in 
other areas of neurology and the 
clinical neurosciences. 
Hafler succeeds Stephen 
G. Waxman, m.d.,ph.d., the 
Bridget Marie Flaherty Professor 
of Neurology, Neurobiology, and 
Pharmacology, who has led the 
department since 1986 and will 
remain on the faculty and con-





johnh.krystal,m.d. ’84, was 
named chair of the Department of 
Psychiatry, effective July 1. Krystal, 
the Robert L. McNeil, Jr., Professor 
of Translational Research, will also 
serve as chief of psychiatry at Yale-
New Haven Hospital. He is director 
of the Center for the Translational 
Neuroscience of Alcoholism, 
and he also heads the Clinical 
Neuroscience Division of the 
Veterans Affairs National Center 
for Post-Traumatic Stress Disorder 
and the Veterans Affairs Alcohol 
Research Center at Yale. Since 
2000, he has served as the depart-
ment’s deputy chair for research.
Krystal is an internationally 
renowned expert on the neurobiol-
ogy and treatment of schizophre-
nia, alcoholism, depression, and 
ptsd. His work is distinguished 
by its emphasis on translational 
neuroscience, the effort to com-
bine emerging brain imaging and 
molecular genetic technologies 
with psychopharmacology to bet-
ter understand alterations in brain 
function associated with psychiatric 
disorders. His research on the gluta-
mate system in the brain has led to 
new experimental treatments for 
several psychiatric disorders. 
Krystal succeeds William H. 
Sledge, m.d., who led the depart-
ment as interim chair during 
the past year, and Benjamin S. 
Bunney, m.d., who served as  
chair for two decades until his 
retirement in 2008. 
contributions to theoretical or ap-
plied science or engineering.
The newly elected members, 
who were introduced at the 
academy’s annual meeting at the 
New England Air Museum in May, 
are Michael Donoghue, ph.d., the 
G. Evelyn Hutchinson Professor 
of Ecology and Evolutionary Biol-
ogy and vice president for West 
Campus Planning and Program 
Development; Peter Jones, ph.d., 
the James E. English Professor of 
Mathematics and Applied Math-
ematics; John H. Krystal, m.d. ’84, 
the Robert L. McNeil Jr. Professor 
of Translational Research; Lynne J. 
Regan, ph.d., professor of molecu-
lar biophysics and biochemistry 
and of chemistry; Peter Salovey, 
ph.d., University Provost and the 
Chris Argyris Professor of Psychol-
ogy; William C. Sessa, ph.d., pro-
fessor of pharmacology; Robert 
S. Sherwin, m.d., the C.N.H. Long 
Professor of Medicine and direc-
tor of the Diabetes Endocrinol-
ogy Research Center; Abraham 
Silberschatz, ph.d., chair  
and Sidney J. Weinberg Professor 
of Computer Science; Joann B. 
Sweasy, ph.d., professor of thera-
peutic radiology and genetics; 
William V. Tamborlane, m.d., fw 
’77, professor and section chief of 
pediatric endocrinology; and Kyle 
T. Vanderlick, ph.d., dean of the 
Yale School of Engineering and 
Applied Science and professor of 
chemical engineering.
The Michael J. Fox Foundation 
awarded $125,000 in April to 
Yale biomedical engineers Mark 
Saltzman, ph.d., chair and the 
Goizueta Foundation Professor 
of Biomedical Engineering in 
the School of Engineering and 
Applied Science, and Michael 
Levene, ph.d., assistant profes-
sor of biomedical engineering, 
for research on the obstacles to 
Stephen G. Waxman, m.d., ph.d., 
the Bridget Flaherty Professor 
of Neurology, Neurobiology, 
and Pharmacology, received the 
William S. Middleton Award, the 
highest scientific honor bestowed 
by the Department of Veterans 
Affairs, at the U.S. Capitol in 
Washington in April. The award 
includes a cash prize of $150,000 in 
research support.
Waxman was honored for his 
research on spinal cord injury, 
multiple sclerosis, and painful 
nerve injuries. His research was 
the first to show the changes 
in molecules within nerve 
cells that permit remissions—
recovery of such lost functions 
as vision and motor control—in 
multiple sclerosis. He has also 
identified key molecules respon-
sible for pain after nerve and 
spinal cord injury.
Waxman is the director of the 
Neuroscience and Regeneration 
Research Center, a collaborative 
enterprise of Yale University, the  
Department of Veterans Affairs,  
the Paralyzed Veterans of 
America, and the United Spinal 
Association. He is also co-director 
of the Yale-London Collaboration 
on Nervous System Injury at Uni-
versity College London. Having 
served as chair of neurology since 
1986, Waxman is now making 
the transition to a full-time role 
as director of the research center 
at the VA Connecticut Healthcare 
System in West Haven.
Eleven Yale faculty members, 
including six from the School of 
Medicine, were elected to the 
Connecticut Academy of Science 
and Engineering in April in recog-
nition of their contributions to  
the advancement of science. 
Scientists and engineers elected 
to the academy must achieve 








drug delivery in regions of the 
brain affected by Parkinson dis-
ease. Saltzman and Levene will 
develop new imaging techniques 
that observe the movement of 
molecules in the brains of living 
animals. These techniques will 
make it possible to track the way 
in which drugs important for the 
treatment of Parkinson disease 
move to their target areas under 
different conditions. 
Levene is a pioneer of deep 
brain imaging using multiphoton 
microscopy in living animals. This 
study will expand the technology 
to include molecular tracking of 
drugs as they traverse the brain.
Saltzman has published 
widely on the development of 
efficient drug delivery technol-
ogy, including the recent addi-
tion of water-soluble polymers 
to chemotherapeutic drugs to 
allow deeper and more stable 
delivery to various locations in 
the brain.
Michael C. Crair, ph.d., was 
named the inaugural William 
Ziegler III Associate Professor of 
Vision Research at the School of 
Medicine this spring. Crair studies 
the ways in which the eye gets 
wired to the brain during fetal de-
velopment. He uses a broad range 
of experimental techniques, 
including in vitro and in vivo 
electrophysiology and optical im-
aging, to examine neural-circuit 
development and to investigate 
the cellular and molecular mecha-
nisms for sensory map develop-
ment. Research from his lab will 
help advance understanding of 
the ways in which a combination 
of genetic instruction and sensory 
experiences can lead to develop-
mental disorders related to vision. 
Pietro De Camilli, m.d., fw ’79, 
the Eugene Higgins Professor 
of Cell Biology, has received a 
$100,000 Distinguished Investi-
gator Award from narsad, the 
leading charity advancing treat-
ment of mental health disorders. 
The one-year grant will help sup-
port his research into the role me-
tabolism plays in the regulation 
of brain function and its impact 
on autism, bipolar disorders, and 
schizophrenia. De Camilli is one of 
16 scientists honored by narsad 
this year.
Thomas M. Gill, m.d., fw ’94,  
a leading authority on the  
epidemiology and prevention  
of disability among older per-
sons, was named the Humana 
Foundation Professor of Geriatric 
Medicine this spring. Gill is co-
director of the Yale Program on 
Aging and of the Claude D. Pepper 
Older Americans Independence 
Center. His research is focused on 
understanding the mechanisms 
underlying the development of 
functional decline and disability 
among community-living older 
persons and on developing pre-
ventive strategies to forestall the 
onset and progression of disabil-
ity among frail at-risk elders. His 
other research interests include 
the epidemiology and preven-
tion of bathing disability and the 
epidemiology of frailty among 
older adults. 
Jeffrey R. Gruen, m.d., hs ’83,  
associate professor of pediat-
rics and genetics, has received 
a $5.2 million grant from the 
Manton Foundation in New York 
City to further his research on 
the genetics of dyslexia. Gruen’s 
discovery of a gene involved in 
dyslexia was named one of the 
top 10 scientific breakthroughs  
of 2005 by the journal Science. 
Gruen will use the grant monies 
to launch a new study that will 
compare the complete genomes 
of 1,000 dyslexic children with 
those of 1,000 fluent readers  
to obtain a fine-grained view of  
genes known to play a role in 
reading disabilities, and possibly  
to identify new genes that increase 
the risk of developing dyslexia. 
Susan Kaech, ph.d., assistant 
professor of immunobiology, is 
one of 50 researchers named Early 
Career Scientists by the Howard 
Hughes Medical Institute (hhmi). 
This award was created by the 
hhmi to fuel the creative energy 
of young scientists strained by 
reductions in federal funding in 
scientific research and education. 
The award includes a research 
grant of $1.5 million over six years 
to support Kaech’s research. 
Kaech is an expert on protective 
T-cells generated by the immune 
system to combat infections.  
In particular, she is focusing on  
memory T-cells, which are long- 
lived cells that remember patho-
gens from prior infections and 
can provide long-term protec-
tion against reinfection. Kaech 
is working on ways to enhance 
responses to infection and to 
improve vaccines.
Shirleen Roeder, ph.d., profes-
sor of molecular, cellular, and 
developmental biology, the 
Eugene Higgins Professor of 
Genetics, and a Howard Hughes 
Medical Institute investigator, 
has been named to the National 
Academy of Sciences. Roeder is at 
the forefront of scientific research 
in molecular genetics; she was 
part of a Yale team that fully 
characterized the function of the 
yeast gene. Roeder specializes in 
meiotic chromosome behavior 
and cell cycle checkpoints. In 
the laboratory, she is studying 
a special type of cell division 
called meiosis, which is neces-
sary for sexual reproduction, by 
isolating and characterizing yeast 
mutants with defective meiotic 
processes. She has written nearly 
100 scientific articles that have 
appeared in such journals as Cell, 
Science, Genetics, and Molecular 
Cell Biology. 
Michael Sernyak, m.d., hs ’87, 
professor of psychiatry, was 
appointed director of the Con-
necticut Mental Health Center 
(cmhc), effective July 1. Sernyak 
was nominated by Yale University 
and appointed by Thomas Kirk, 
ph.d., the commissioner of the 
Connecticut Department of Men-
tal Health and Addiction Services. 
Sernyak, who replaces the retiring 
Selby Jacobs, m.d., served as unit 
chief of the Psychosis Studies 
Unit at cmhc for five years. In 
1996 he joined the staff at the VA 
Connecticut Healthcare System 
in West Haven and in 2001 was 
appointed chief of the psychiatry 
service. Sernyak is a nation-
ally recognized health services 
researcher who specializes in 
treatment issues of the severely 
mentally ill. His most recent 
areas of focus have been the 
development of such metabolic 
abnormalities as diabetes and 
the delivery of medical care in 
patients with schizophrenia.
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A day to reflect on 
becoming a doctor
The Class of 2009 enters medicine at a 
time of change and an ongoing debate 
over health care.
For the 96 members of the Class of 
2009, Commencement was a day 
of sunshine and serious reflection 
on the nature and responsibilities of 
being a doctor.
Commencement speaker David 
Blumenthal, m.d., national coordina-
tor for health information technology 
at the U.S. Department of Health 
and Human Services, exhorted the 
t o p  Lawrence Cohen and bagpiper Glenn 
Pryor led the procession to Commencement 
ceremonies at Amistad Park. 
abov e  Fabienne Meier-Abt, Sarah Milgrom, 
Kathleen Samuels, Aviva Romm, and Titilope 
Oduyebo waited at Cross Campus for the 
procession to Old Campus for the university 
Commencement.
r i ght  Sheela Smith-Rohrberg Maru and Duncan 
Smith-Rohrberg Maru bottle-fed their infant 










graduates to engage in the debate on 
health care reform. “We are witness-
ing a crisis in the system of care, upon 
which we all rely as patients and with-
out which you, and all the classes that 
follow you, cannot effectively apply your 
art and skills,” Blumenthal said. He 
spoke of the rising cost of health care 
in the United States, and he framed the 
current economic and political climate 
as an ideal moment for change as more 
people lose employment-based health 
insurance. “Timing is everything, and 
we are now seeing a combination of cir-
cumstances that is rare in the history of 
our country and of health reform.”
Blumenthal drew parallels between 
the Obama administration and that 
of President Lyndon Johnson, which 
enacted Medicare and Medicaid. Then as 
now, he said, three forces converged—a 
crisis in health care, a bipartisan desire to 
effect change, and presidential leadership 
on the issue. No true health care reform 
can take place, Blumenthal said, without 
the support of the nation’s young physi-
cians, and he encouraged the graduates 
to stay involved in reform efforts through-
out their careers. “It can make you a bet-
ter physician, and it can certainly make 
the lives of your patients better.” 
In his invocation at the ceremony 
in Amistad Park, Jason Frangos,  
m.d. ’09, described the process of 
moving through medical studies into 
the heart of doctoring. “We may look 
back to when we first arrived, when 
we first received our portions of unre-
fined ore,” he said. “We smelted and 
forged and hammered into iron in the 
blast heat of hard work, studying and 
memorizing, dissecting and discover-
ing, listening and loving. … We ham-
mered, tempered, and wrought into a 
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tiny spinning needle … a compass that 
is our heart.”
Commencement awards
This year’s Bohmfalk Prizes for excel-
lence in teaching went to Michael L. 
Schwartz, ph.d., associate professor of 
neurobiology, for basic science; and to 
Frederick D. Haeseler, m.d., associate 
clinical professor of internal medicine 
and director of primary care clerkships, 
for clinical science.
Grace Y. Jenq, m.d., assistant profes-
sor of medicine (geriatrics), received 
the Leonard Tow Humanism in Medi-
cine Award. The Leah M. Lowenstein 
Award went to Laura R. Ment, m.d., 
associate dean for admissions and 
financial aid and professor of pediat-
rics and neurology.
The Alvan R. Feinstein Award went 
to Robert M. Rohrbaugh, m.d., associate 
professor of psychiatry. Karen J. Jubanyik, 
m.d., assistant professor of surgery (emer-
gency medicine), received the Francis 
Gilman Blake Award. The Betsy Winters 
House Staff Award went to Joshua 
Silverstein, m.d.
The Class of 2009 donated its 
class gift to the Mila Rainof Memorial 
Fund, to help those “who choose the 
same path we have chosen,” according 
to the class presidents. 
—Ayelet Amittay
t o p le f t  In March, Heather Wachtel celebrat-
ed her match to a general surgery residency at 
the Hospital of the University of Pennsylvania. 
t o p r i ght Medical student Aimee Two 
explained her neurobiology poster at Student 
Research Day in June. She was one of 70 
students who presented posters on research 
in laboratory science, clinical findings, medical 
humanities, and international health.
abov e Ongoing renovations caused Student 
Research Day to move from its traditional home 
in the Jane Ellen Hope Building to The Anlyan 
Center this year.
Online Extra
A complete Commencement 
photo gallery can be found at 
yalemedicine.yale.edu.
Online Extra
Visit the Online Extra section of Yale Medicine’s 
website at yalemedicine.yale.edu to access 
more photographs and full coverage of stu-

































Patricia Nez Henderson, the first female  
American Indian graduate of the Yale School of 
Medicine, combines science and the spiritual  
in her practice of medicine.
A Navajo doctor tends  
to the spirit and body
Patricia Nez Henderson integrates a 
concept of balance and harmony into 
her thinking about medicine.
When Patricia Nez Henderson, m.p.h. ’94, 
m.d. ’00, was a child in rural Arizona, 
her grandfather would come to her house 
early in the morning and splash water 
on her and her siblings. “Get up! Get up! 
Go run and meet the rising sun,” he told 
them in Navajo. “If you sleep too much, 
you’re going to be left behind, and the 
morning gods are ready to bless you.” 
The children would jump out of bed and 
run toward the glow in the east.
From growing up in a Navajo-speaking 
community without electricity or run-
ning water to completing medical 
school as Yale’s first female American 
Indian graduate, Nez Henderson’s was 
a remarkable journey. Her interest in 
medicine began early, influenced by her 
grandfather—a medicine man—and 
other traditional healers in her family. 
Most of her relatives worked as shep-
herds, and she recalls listening to lambs’ 
hearts with a stethoscope her mother 
had bought her. “I’d come home smell-
ing like manure,” she said. “My mother 
says that’s when she first realized I’d go 
into medicine.”
Nez Henderson earned her m.p.h. 
at the School of Public Health in 1994 
after earning a degree in biochemistry 
at the University of Arizona. Then it was 
on to medical school. 
It was there that culture shock took 
hold. Having grown up among healers  
who took patients’ spiritual as well 
as physical health into account, Nez 
Henderson felt miserable at an allopathic 
school. “My heart was dissected from 
my head,” she said. “I felt it immediately 
upon getting into med school, and there 
were no other Native students there, 
so it was hard to explain to students or 
even my professors what I was going 
through.” One day a faculty member 
made a thoughtless comment about her  
imperfect command of English. It dev-
astated her. At that moment, she said, 
she understood why so many American 
Indian students leave school. “All I saw 
was a room full of men in white jackets, 
predominantly white, and I just began to 
cry, [thinking] ‘I don’t belong here.’ ”
Shortly afterward, Peterson Zah, a 
former president of the Navajo Nation, 
came to speak at Yale. Before his speech, 
Nez Henderson met with him privately 
and told him what had happened. Later, 
as he addressed the crowd, he turned 
directly to her and spoke words of en-
couragement in Navajo, whereupon she 
decided to stay at Yale. 
After earning her m.d., along with 
an award in her name given to recog-
nize a graduate committed to improv-
ing health among American Indians, 
Nez Henderson went to Colorado. Her  
sense that allopathic medicine is in-
sufficient—as well as the frustration 
among physicians she had witnessed 
during clinical rotations at underfunded 
Indian Health Service sites—had 
convinced her to pursue public health 
research. She joined the faculty of the 
University of Colorado Health Sciences 
Center’s Native Elder Research Center 
for a two-year program that trains Native 
health professionals for research careers. 
Funded by grants from the National 
Institutes of Health, the Centers for 
Disease Control and Prevention, and the 
Robert Wood Johnson Foundation, she 
began to study tobacco control and pre-
vention among American Indians, an 
interest that continues today.
Tobacco has long been sacred to 
Native communities, but its abuse leads 
to disproportionately severe health con-
sequences for them. Nez Henderson 
studies American Indians’ reactions 
to nicotine, which may have genetic 
underpinnings. She has also designed 
Web-based interventions and smoking 
cessation classes that incorporate tribal 
practices like prayers, visits to sweat 
lodges, and fasting, and that emphasize 
the sacredness of life. “Navajo tribes use 
a word, hozho, which means ‘in balance’ 
or ‘it’s beautiful.’ There’s that harmony,” 
she said. “Anything that impacts hozho 
and makes it go out of balance, we know 
that’s toxic, like cigarettes. … It’s a more 
holistic approach. Instead of just tell-
ing a person to do these things that are 
backed by evidence, you combine it with 
things that are spiritual.”
Nez Henderson lives in South Dakota 
with her husband Jeffrey A. Henderson, 
m.p.h., m.d., an internist who is Lakota 
Sioux, and their daughter, Zahlanii, 7, 
and son, Mato, 5. They head the Black 
Hills Center for American Indian Health 
in Rapid City. In addition to her research, 
Nez Henderson works with tribal leaders 
to effect tobacco policy changes within 
the Indian nations. “With sovereignty 
comes responsibility,” she said. “A lot of 
tribes are looking at ways to bring eco-
nomic development into their communi-
ties, but if they put health first, all that 
they’re looking for will come next.
“I work all the way from prevention 
to cessation to policy,” she said. “I abso-











During this year’s reunion, about a dozen alumni 
toured Smilow Cancer Hospital, which is sched-
uled to open in October. From the ground floor, 
the group took elevators to the upper floors 
for views of still-unfinished offices and suites, 
with grand views of New Haven. The tour also 
took in new operating rooms—where all cancer 
surgery at Yale-New Haven Hospital will take 
place—and infusion suites. The 14-story facility 
will contain nearly 500,000 square feet and will 
include 112 inpatient beds, outpatient treatment 
rooms, expanded operating rooms, infusion 
suites, diagnostic imaging services, and floors 
for diagnostic and therapeutic radiology.
and serving as national president of the 
Society of Head and Neck Surgeons, 
which became the American Head 
and Neck Society in 1998. Charlotte 
Newsom Shedd, m.n., r.n. ’46, who 
passed away two years ago at the age of 
84, co-founded Hospice Buffalo, often 
working from the dining room table 
while caring for her aging mother and 
the youngest of the four Shedd children. 
She traveled around the country as an 
early pioneer of the hospice movement 
at the national level. 
Both Shedds had high levels of energy. 
Now professor emeritus at suny Buffalo, 
Shedd still attends weekly tumor board 
meetings. He also maintains a database 
of head and neck operations at the  
cancer institute, where he was chief of 
head and neck surgery for 29 years.  
In 2007, the department published his 
fifth book, a history of head and neck 
surgery at Roswell. Shedd is also the 
author of Historical Landmarks in Head 
and Neck Cancer Surgery and The Early 
History of Hospice Buffalo. 
“You become conscious of a decrease 
in energy in your mid-80s,” said the 
surgeon, who gave up windsurfing on 
Lake Erie around age 75. But he still 
plays tennis and maintains a regular 
exercise schedule. He has helped build 
houses for Habitat for Humanity and 
is an active member of the Unitarian 
Universalist Church of Buffalo, where 
he moderates a discussion group, serves 
on committees, and participates in a 
monthly book club.
Shedd earned his bachelor’s degree 
at Yale and began his study of medi-
cine in an accelerated program during 
At 86, head and neck surgeon 
still contributes to medicine and 
hospice cause he helped found
One medical school memory that Donald 
P. Shedd, m.d. ’46, hs ’53, holds dear 
is of the day he walked into the “croup 
room” at Grace-New Haven Community 
Hospital and peered through the mist 
that was then used to treat children with 
the characteristic barking cough. There 
he caught his first glimpse of his future 
wife, a Yale nursing student named 
Charlotte Newsom. “You can imagine 
how glamorous a woman looks in a 
steam room,” he said. She turned out 
to be lovely, a gifted pianist who played 
Chopin beautifully. They married and 
launched two brilliant careers.
Shedd, now 86, ended up joining the 
Yale faculty, later became chief of head 
and neck surgery at the Roswell Park 
Cancer Institute in Buffalo, New York, 
Online Extra
Visit the Online Extra section of Yale  
Medicine’s website at yalemedicine.yale.edu 
to access more photographs and full coverage 








Donald Shedd, a head and neck surgeon in 
Buffalo, N.Y., was an early supporter of the 
















World War II, when faculty members 
were leaving to serve in the military 
and medical students were hired to 
deliver emergency anesthesia at night. 
During his 14 years on the Yale faculty, 
he became increasingly interested in the 
care of head and neck cancer patients. 
He moved to Roswell Park in 1967. “The 
job offer in Buffalo was an excellent 
one,” Shedd said. “It was one of the best 
positions in the field in the country.” 
Shedd describes himself as “a mod-
est contributor” to head and neck sur-
gery during what he calls “a fascinating 
period” of advances in medicine. “I’d say 
there have been modest gains in head 
and neck cancer survival and major 
gains in quality of life, both cosmetically 
and functionally,” he said. “One of my 
contributions to care at Roswell Park 
was the incorporation of the use of the 
surgical microscope in endoscopic diag-
nosis. It made diagnosis more precise,” 
he said. As a faculty member at Yale, he 
conducted radiographic studies of swal-
lowing in inpatients after head and neck 
surgery. “I did some work at Roswell in 
surgical approaches to speech rehabilita-
tion after laryngectomy,” he said.
In addition to his clinical work and 
research, Shedd helped train fellows 
and residents who began their careers at 
Roswell Park. He was involved in medi-
cal service in Peru and Nicaragua, as well 
as short surveys of oral cancer research in 
India, Pakistan, and Ceylon (now called 
Sri Lanka). He also held a visiting profes-
sorship in South Africa.
While his own career was demanding 
enough, Shedd shared his wife’s pas-
sion for hospice care. The contemporary 
American hospice movement began in 
New Haven when the Shedds and others 
attended a talk at Yale by Dame Cicely 
Saunders, the Englishwoman regarded as 
the founder of the modern hospice move-
ment. “We kept talking about it after 
we came to Buffalo. We realized there 
was a need for such a facility here, so 
we formed a founding committee, then 
Charlotte took the initiative,” he said. The 
couple also collaborated on a survey of 
the final period of life in 60 head and 
neck cancer patients. Charlotte received 
a distinguished alumna award from the 
School of Nursing in 1992.  
Shedd said the support he and his 
wife provided each other throughout 
their careers and retirement was crucial. 
He considers it a privilege to have been 
able to care for Charlotte at home during 
her encounter with Alzheimer disease. 
She spent her final day in the hospice 
inpatient unit she had helped to establish.
“Joseph Campbell said something 
about following your bliss,” Shedd said, 
referring to the scholar who wrote 
about the power of mythology to explain 
human experience. “I think I have been 




Do you have a colleague who is making  
a difference in medicine or has followed 
an unusual path since leaving Yale? We’d 
like to hear about alumni of the School of 
Medicine, Physician Associate Program, 
and the medical school’s doctoral, fellow-
ship, and residency programs. Drop us a 
line at ymm@yale.edu or write to Faces, 
Yale Medicine, 300 George Street, Suite 
773, New Haven, CT 06511.
2009-2010
Association of Yale 
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Harold Bornstein Jr., m.d. ’53, hs ’56
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Christine A. Walsh, m.d. ’73 
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Jennifer M. Blair, m.d. ’04 
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Douglas A. Berv, m.d. ’74 
Sharon L. Bonney, m.d. ’76 
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Ellen B. Milstone, m.d. ’69, hs ’70 
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WANTE D :  IM AGES OF YESTE RYE AR
In preparation for the School of Medicine’s Bicentennial in 2010, Yale Medicine is 
seeking archival photographs, motion pictures, videos, and sound recordings 
depicting the history of the school and its students, faculty, and alumni. 
Areas of interest include medical education, student life, medical 
practice, and scientific research. Please let us know if you have materials that 
could be borrowed or duplicated. All formats are acceptable, including photo-
graphic prints, slides, digital files, film and 
tape reels, and cassettes. Write to us at 
ymm@yale.edu [subject line: Bicentennial 
images] or via U.S. mail to Bicentennial 
Images, Yale Medicine, 300 George Street, 
Suite 773, New Haven, CT 06511. To join the 
Bicentennial news and events mailing list, 
visit medicine.yale.edu/alumni.
Richard LambAaron Beck Gualberto 
Ruaño
Jiyon LeeAnthony Proto Eduardo  
Alfonso
1940s
Aaron T. Beck, m.d. ’46, received 
the 2009 Award for Extraordi-
nary Accomplishment in Medical 
Research from the Robert J. and 
Claire Pasarow Foundation in May. 
The $50,000 award is one of three 
given each year for basic or clinical 
research in cancer, cardiovascular 
disease, and neuropsychiatry. Beck, 
the University Professor Emeritus 
of Psychiatry at the University of 
Pennsylvania School of Medicine, 
is a member of the Institute of 
Medicine and the National Acad-
emy of Sciences.
1950s
Richard Lamb, m.d. ’54, received 
the 2009 Distinguished Service 
Award from the American Psychi-
atric Association. The award honors 
individuals and organizations that 
have contributed meritorious 
service to American psychiatry.
1970s
Katherine Benesch, m.d. ’70, j.d., 
a partner in the health law prac-
tice group at the Princeton, N.J., 
office of Duane Morris llp, was 
appointed to the American Arbi-
tration Association (aaa) Health 
Care Advisory Council in March. 
The council is a national group 
appointed by the aaa to develop 
dispute resolution solutions for 
the health care industry.  
Anthony V. Proto, m.d. ’71, was 
awarded the 2008 Gold Medal of 
the Radiological Society of North 
America (rsna) for his contri-
butions to radiology. The Gold 
Medal requires the unanimous 
approval of the rsna board of 
directors. Proto, who recently 
completed more than 10 years as 
editor of the journal Radiology, 
is a professor of radiology at Vir-
ginia Commonwealth University 
Medical Center.
1980s
Eduardo C. Alfonso, m.d. ’80, the 
Edward W.D. Norton Professor of 
Ophthalmology, was named chair 
of Bascom Palmer Eye Institute, 
the Department of Ophthalmol-
ogy of the University of Miami 
Miller School of Medicine, in June. 
A 1984 graduate of the institute’s 
residency program, Alfonso has 
been on the faculty since 1986. He 
is known for his clinical expertise 
in diseases and surgery of the 
cornea and in ocular microbiology 
and laser vision correction.
1990s
Matthew B. Klein, m.d. ’97, has 
been named the David and Nancy 
Auth-Washington Research 
Foundation Endowed Chair for 
Restorative Burn Surgery at the 
University of Washington. Klein 
is associate professor of plastic 
surgery, associate director of the 
University of Washington Burn 
Center, and director of the plastic 
surgery residency program.
Jiyon Lee, m.d. ’96, assistant pro-
fessor of radiology (breast imag-
ing) at New York University (nyu) 
School of Medicine, was honored 
at the American Cancer Society’s 
(acs) Diamond Luncheon in May 
for her volunteer work with the 
acs in Westchester County, N.Y. 
Lee has been serving as medical 
director and a member of the 
board of advisors for the past five 
years. She is a mammographer 
at the nyu Clinical Cancer Center 
and at Bellevue Hospital Center 
in New York City.
Gualberto Ruaño, ph.d. ’92,  
m.d. ’97, was inducted into the 
American Institute for Medical 
and Biological Engineering’s 
College of Fellows in April at a 
ceremony in Washington, D.C.,  
at the National Academy of 
Sciences. Recipients of this 
honor are chosen for exceptional 
leadership and achievements in 
medical and biological engineer-
ing. Ruaño is president and chief 
executive officer of Genomas 
Inc., a biomedical company based 
in Hartford, Conn.; director of 
genetics research at Hartford 
Hospital; and adjunct profes-
sor in the medical faculties of 
George Washington University 
and the University of Puerto Rico. 
send alumni news to
Claire M. Bessinger, Yale Medicine,
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu







































John R. Brobeck, ph.d., m.d. ’43, 
died of pneumonia on March 6 
at a retirement community in 
Media, Pa. He was 94. Brobeck 
served on the Yale faculty 
from 1942 until 1952. Brobeck 
then chaired the physiology 
department at the University of 
Pennsylvania School of Medicine 
from 1952 until 1973 and for 10 
years served as assistant to the 
vice president for health affairs. 
He was elected to the National 
Academy of Sciences in 1975.
Seth D. Charney, m.d. ’69, died 
at his home in San Francisco on 
March 8. He was 64. Charney 
served as a student editor of the 
Journal of the History of Medicine 
during his years at Yale. He prac-
ticed psychiatry in San Francisco, 
owned real estate throughout 
California, and was a lifetime 
champion of human rights causes. 
Edwin L. Child, m.d. ’56, died on 
February 14 of brain cancer at his 
home in Manchester, N.H. He 
was 78. Child was an obstetrician/
gynecologist who delivered thou-
sands of babies during his career 
and made medical mission trips 
to Liberia, Jamaica, and Kenya. 
William F. Collins Jr., m.d. ’47, 
the Harvey and Kate Cushing 
Professor Emeritus of Neurosur-
gery and former chair of surgery, 
died on June 17 in San Diego. He 
was 85. Collins accepted the 
position of professor and chief 
of neurosurgery at Yale in 1967. 
In 1970, he was appointed the 
Harvey and Kate Cushing Profes-
sor of Surgery. He remained chief 
of neurosurgery at the medical 
school and neurosurgeon in chief 
at Yale-New Haven Hospital until 
1984, when he was appointed 
chair of the Department of 
Surgery. He retired as chair in July 
of 1993 and assumed emeritus 
status in the Department of 
Surgery on July 1, 1994. 
Lycurgus M. (Bill) Davey, m.d. ’43, 
died on June 15 in New Haven 
as a result of injuries from a fall. 
He was 91. Davey was a clinical 
professor of neurosurgery who 
devoted much of his career to 
clinical teaching and the training 
of Yale neurosurgical residents. 
He served as president of the 
Association of Yale Alumni in 
Medicine from 1995 to 1997. He 
read five languages and drew 
on his classical education as he 
explored and wrote about the 
history of medicine, includ-
ing an article about the Greek 
inscription above the entrance to 
Sterling Hall of Medicine. He was 
an active consultant and clinical 
professor in the Department of 
Neurosurgery at Yale from 1951 
to the present. His recent awards 
include the Distinguished Alumni 
Service Award in 1997 and the 
Peter Parker Medal in 2003 
for outstanding service to the 
School of Medicine. 
William K. Frankenburg, m.d., 
m.s.p.h., fw ’63, an internation-
ally recognized pioneer in child 
development and pediatric 
preventive medicine, died on 
April  3 of acute myeloid leuke-
mia at his home on Bainbridge 
Island, Wash. He was 78. In 1967, 
Frankenburg and his colleague 
at the University of Colorado, Jo-
siah Dodds, ph.d., published the 
Denver Developmental Screen-
ing Test, known as the Denver II, 
which has been used to screen 
millions of children around the 
world for developmental delays. 
Stuart L. Joslin, m.d. ’43, died on 
January 25 after a short illness in 
North Adams, Mass. He was 93. 
Joslin was one of the founding 
directors of the Mid-Fairfield 
Child Guidance Center and chair 
of the Well Baby Clinic, both in 
Connecticut, where he practiced 
pediatrics until his retirement 
in 1991.
Alan D. Lieberson, j.d., m.d. ’62, 
died at his home in Westport, 
Conn., on February 10. He was 71. 
Lieberson used his knowledge of 
law and medicine to tackle such 
medical questions as eutha-
nasia, living wills, and health 
care rationalization. He was a 
partner at Internal Medicine of 
Westport for 15 years and served 
on the medical ethics commit-
tee of Norwalk Hospital.
Daniel L. Macken, med ’59, m.d., 
died on March 1 in New York City. 
He was 75. Macken served as a 
lieutenant colonel in the Army 
Medical Corps during the Viet-
nam War. He was honored by the 
United States and the Republic of 
South Vietnam for his wartime 
medical service. At Columbia 
University he founded the Medica 
Foundation to support medical 
research and activity.
Henry E. Markley, m.d. ’43, died 
on February 26 in Greenwich, 
Conn. He was 90. Markley 
practiced medicine in Greenwich 
from 1950 until 1979, and in 1955 
launched Greenwich Hospital’s 
Home Care Program for the eld-
erly, sick, people with disabilities, 
and children with special needs.
Robert W. Ollayos, m.d. ’41, died 
on February 23 in a nursing facil-
ity near St. Louis of complications 
of Alzheimer disease. He was 
92. Ollayos, a flight surgeon in 
the Army Air Corps during World 
War II, conducted research that 
contributed to the development 
of lifesaving equipment for 
babies born with Rh-blood type 
incompatibility. 
Vincent Pepe, m.d. ’46, hs ’52, an 
obstetrician-gynecologist who 
delivered more than 10,000 
babies during 60 years in private 
practice, died on June 20 of con-
gestive heart failure in Meriden, 
Conn. He was 87.
Pepe, a native of New Haven, 
began his practice in the Meriden-
Wallingford area in 1952. In the 
1950s, he helped to forge the use 
of prenatal folic acid to prevent 
birth defects and later helped 
to pioneer work in urological 
gynecology. He also helped to 
advance surgical treatments for 
urinary incontinence for women 
as well as laparoscopic opera-
tive techniques and ultrasound 
procedures in community-based 
ob-gyn practice. 
Richard C. Petersen, m.d. ’48, 
died on February 1 at his home in 
Southbury, Conn. He was 85. In 
1955 Petersen opened a pediatric 
practice in Stratford, Conn., and 
became a leader in preventive 
pediatric care.
Samuel M. Rice, m.d. ’49, died 
on March 3 in Cranberry, Pa. He 
was 86. After graduating from 
medical school, Rice returned 
to the Pittsburgh area and 
practiced medicine out of his 
house in Cranberry from 1953 
until 2003, making house calls 
and seeing the same patients 
for decades.
Micky Ray Riggs, m.d. ’92, died on 
December 26 in Seattle. He was 
52. Riggs was remembered for his 
insights on topics ranging from 
global politics to serial killers to 
SpongeBob SquarePants.
Susan S. Spencer, m.d., professor 
of neurology and neurosurgery, 
died suddenly on May 21 in Salt 
Lake City. She was 60. Spencer 
was an internationally recog-
nized expert in epilepsy, and 
particularly in epilepsy surgery. 
She was the co-director of the 
Yale Epilepsy Program with her 
husband, Dennis D. Spencer, m.d., 
hs ’77, chair of neurosurgery. She 
came to Yale as a resident in neu-
rology in 1975, following under-
graduate and medical school 
education at the University of 
Rochester, and joined the faculty 
in 1980. She soon wrote major 
papers in epilepsy surgery and 
published more than 200 original 
manuscripts and chapters on 
the subject. Her contributions 
were recognized by the American 
Epilepsy Society Clinical Research 
Award in 2003.
send obituary notices to
Claire M. Bessinger, Yale Medicine,
300 George Street, Suite 773, 
New Haven, CT 06511, or via e-mail 
to claire.bessinger@yale.edu
end note
Glass blower Daryl Smith produces made-to- 
order glass implements and instruments for 
Yale scientists. “I like working with my hands, 








A TOuch OF Gl A SS
At this most modern of universities, with its particle accelerators, 
radiochemistry facility, and stem cell center, a lone craftsman in a 
small workshop helps unravel today’s scientific mysteries using tech-
niques developed centuries ago.
Daryl Smith is Yale’s scientific glass blower. At the Yale Glass 
Shop in the Sterling Chemistry Laboratory, Smith helps scientists and 
researchers design the equipment they need for their experiments. 
“Anything they see in a catalog I can make and customize to fit their 
specific needs,” said Smith, who came to Yale in 2005 after working 
for private glass companies. He completed his undergraduate degree 
in aquaculture from Texas A&M University in College Station and 
studied scientific glass technology at Salem Community College in 
Carneys Point, N.J. “I like working with my hands,” he said, “but I like 
the science part of it, too.”
Smith also teaches a semesterlong course titled “Introduction 
to Scientific Glass Blowing,” which focuses on the dexterity needed 
to be a glass blower as well as the tools and materials. Last spring, his 
six students watched a brief demonstration by Smith before begin-
ning their final project, a Hero’s engine—a device invented by Hero of 
Alexandria around A.D. 10 that propels itself by shooting steam from 
one or more orifices.
Many research universities outsource their glasswork to pri-
vate companies, but Smith can meet face to face with researchers 
to develop customized products, and he can create or repair a device 
the same day if necessary. But perhaps most important, Smith’s loy-
alty is to Yale, so when he and a researcher develop a new design, he 
treats it as proprietary information; he won’t share it as an outside 
contractor might. 
When Smith isn’t creating or repairing scientific equipment at 
Yale, he enjoys the artistic side of glass blowing, creating glass orna-
ments and gifts at his home studio. Not surprisingly, the Christmas 
season is his busiest time. “You’ll find me sitting in front of my bench 
torch,” he said, “instead of going to the mall.”
—Jennifer Kaylin
Online Extra
Video of Daryl Smith at work  
can be seen at yalemedicine.yale.
edu/glassblower.
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